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ABSTRACT
Fractures and segmental bone defects are the primary cause of patient morbidity
and brings a substantial economic burden to the healthcare system. Bone grafts used for
bone injuries, tumors, and other pathologies related to poor fracture healing in the United
States cost considerable money each year. The total cost of treating bone defects is about
5 billion US dollars. Autologous bone transplantation is the ideal method for the
treatment of bone defects. However, their clinical results are variable and increase
postoperative morbidity (especially at the donor site) and surgical costs. To circumvent
these limitations, tissue engineering and cell-based therapies have been proposed as
alternative methods to induce and promote bone repair.
In this study, we have developed a composite photo-crosslinked hydrogel with
favorable mechanical properties and tunable bioactive properties. Furthermore, this
composite hydrogel system, when combined with 3D printed scaffolds, can be modified
to meet various applications for bone tissue regeneration applications. In this study, we
identified the optimal combination between different concentrations of halloysite
nanotubes (HNTs), strontium coated HNTs (SrHNTs), bone morphogenetic protein 2
(BMP-2), collagen methacrylated (COMA), and cross-linking time to develop a suitable
scaffold. The scaffold is biocompatible and biodegradable, but also antibacterial and
should promote faster healing.
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iv
The results suggest that gentamicin+SrHNTs+BMP-2 COMA hydrogel combined
with a polycaprolactone (PCL) scaffold provides an optimal scaffold that can match the
mechanical properties of bone. The next stage is to explore the scaffolds’ application in
biomedical engineering. To do this, animal testing will need to be performed. If the
scaffold works in the animal model it will provide a meaningful treatment plan for bone
tissue repair and regeneration.
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CHAPTER 1
INTRODUCTION

1.1

Bone Defect Repair

Successful treatment of many bone diseases and disorders remains limited due to
a lack of safe and effective means of drug delivery that enhance bone tissue regeneration.
Furthermore, despite significant advances, engineering a scaffold or drug delivery
construct that delivers growth factors in a controlled manner has seldom been attained.
The need for enhanced bone repair therapy, therefore, is a critical clinical concern.
The challenge remains to attain the controlled release of growth factors, such as
BMP-2, in the range of nanograms or picograms per milliliter and over an extended
period of seven to fourteen days, the typical time frame that progenitor cells differentiate
into osteoblasts. In addition, for the hydrogels to be implantable or extruded as a bioink,
they need mechanical properties that enable them to withstand the body’s internal
environment.
Tissue defects are repaired in a series of steps, including infiltration of host
reparative cells (e.g., osteoblast and fibroblast) into the defect site, the proliferation and
activation of the cells, and the deposition of extracellular matrices (ECMs) in the defects
[1-3]. Osteoprogenitor and stem cells are attractive because of their unique ability to selfrenew (multiply as undifferentiated (or pre-committed) cells), to be stored in biobanks,
and to differentiate into various cell types in response to appropriate signals [3].
1
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Cytokines and growth factors are critical signaling agents that control and coordinate
progenitor and stem cell behavior in native bone tissue regeneration [4].
The rapid recruitment of osteoblasts and bone marrow-derived stem cells to
skeletal defect sites and their proliferation and differentiation is essential for effective
bone repair [1,2]. An alternative approach for skeletal repair is the directed selection,
expansion, and modulation of osteoblasts, osteoprogenitor, and stem cells [1,2]. The bone
repair and healing process in damaged or diseased bones could be accelerated if an
increased number of native osteoblasts and progenitor cells were actively recruited to the
site of injury. Upon arrival, these cells would replace diseased, damaged, or senescent
cells and assist in repairing or renewing diseased or damaged tissues.
Several previous studies have used exogenous growth factors to recruit
osteoblasts to the damaged site for a better therapeutic outcome [5,6]. The delivery of
growth factors to the damaged site has become a widely used methodology that facilitates
tissue repair by enhancing host cell recruitment, proliferation, and activation [7,8]. This
approach has shown that faster recruitment of repair cells to the defect site can
significantly reduce the time required for bone tissue repair and remodeling and can thus
enhance bone reconstruction.
In bioengineered materials for bone repair, BMP-7 [9] platelet-derived growth
factor (PDGF) [10], transforming growth factor-b (TGF-b) [11], insulin-like growth
factors, vascular endothelial growth factor [12], and bone morphogenetic protein-2
(BMP-2) [11,12] have been used to manipulate cell behavior. Chemotactic cue-induced
bone repair methods can prevent the migration of other types of cells, such as epithelial
cells [13,14]. However, the application of chemical cues still poses several limitations,
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such as the high cost of growth factors, the short half-life of growth factor proteins in
vivo, and the potential adverse effects of overdose events or pathological conditions
[13,14].
The development of orthopedic implant materials that promote osseointegration
and reduce bacterial infection has gained considerable attention in recent years [15].
Previous studies in our lab have shown that halloysite nanotubes (HNTs) have an
osteoinductive effect and can induce pre-osteoblasts and stem cells to differentiate into
osteoblasts and produce a mineralized bone matrix [14,16]. Furthermore, numerous
studies have shown that halloysite can serve as an excellent nanocontainer for the
delivery of antibiotics [17,18]. As a bulk filler added to a polymer, HNTs provide
material enhancements such as increased adhesiveness, fracture resistance, increased
tension and compressive properties, and enhanced thermal capabilities.
The focus of this dissertation is to develop a system for enhancing the bone repair
process. My dissertation research consists of three related projects that exploited the
critical properties of HNTs for use in bioengineered materials for bone tissue
regeneration. As first demonstrated in our lab, HNTs possess osteoconductive and
osteogenic properties and can induce mesenchymal stem cells (MSCs) and preosteoblasts to differentiate into osteoblasts. We also hypothesize that HNTs are also
chemotactic. Project #1 will directly address the chemotactic potential of halloysite
nanotubes (HNTs) using a transmembrane migration culture system. This knowledge will
then be used to develop a hydrogel system composed of methacrylate collagen and
SRHNTs (Project #2) and to determine its effectiveness in inhibiting bacterial growth as
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well as its tissue regenerative properties. The objective of Project #3 is to apply the
hydrogel composite as a coating for 3D printed bone implants.

CHAPTER 2
BACKGROUND

2.1
2.1.1

Bone Biology

Basic Bone Biology – Matrix Composition
Bones comprise the internal support structure of vertebrates. Their functions are

to move, support and protect the body, and to store minerals. Adults have 212 bones,
while newborns have more than 270 bones [19,20] Human bones are categorized by
shape as long bones, short bones, flat bones, irregular bones, and sesamoid bones (Figure
2-1) [21]. Long bones typically have lengths substantially larger than their width and are
divided into a diaphysis and two epiphyses, which articulate with other bones to form
joints. Inside the epiphyses is a complex honeycomb-like three-dimensional (3D)
structure called spongy bone. Most diaphysis is composed of compact bone tissue, and in
the middle is a bone marrow cavity containing cancellous bone and bone marrow. Most
of the limb bones are classified as long bones (including the phalanges and toes) [21].
The classification of long bones depends on shape rather than size.

5
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Figure 2-1: Bone cell types [22].
Short bones are cuboidal in morphology and the outer part is composed of dense
compact bone and thin laminar bone. The interior is mostly composed of cancellous
bone. The short and sesamoid bones make up the wrist and ankle joints, with some
exceptions including the kneecap (patella), wrist, tarsus, and bones that make up the wrist
and ankle joints. A flat bone is thin and curved, with two layers of dense bone
sandwiching the middle layer of spongy bone. The skull and sternum are examples of flat
bones [23]. An irregular bone, as the name suggests, is a complex-shaped bone, which
does not easily fit in the classifications described above. In flat bones, a thin layer of
dense bone surrounds cancellous bone. The bones of the spine and pelvis are irregular. A
sesamoid bone is wrapped within a connective tissue such as a tendon. Its function is to
keep the tendon away from the joint and increase the angle of tendon bending to increase
muscle contraction, such as the patella and pisiform. Bone is composed of organic matter
and inorganic matter. The organic matter is mainly type I collagen and minor bone
proteins. Type I collagen provides a resilient component and toughness. The inorganic
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matter, primarily calcium and phosphates salts that form hydroxyapatite, gives bone its
hardness. Other tissues associated with bone include bone marrow, periosteum, nerves,
blood vessels, and cartilage.
2.1.2

Bone Cell Types
The cellular components of bone tissue include osteocytes, osteogenic cells,

osteoblasts, and osteoclasts [24]. Only the osteocyte exists within bone tissue, the other
cells are located at the periphery of bone tissue.
Osteoblasts and Osteocytes
Osteoblasts are differentiated from osteogenic cells and are larger than osteogenic
cells. They are short columnar or cuboidal-shaped cells. The nucleus is large and round,
and the nucleoli are prominent (Figure 2-2). When bone grows and regenerates,
osteoblasts are distributed into a regular layer on the surface of bone tissue. They secrete
bone proteins in layers on the surrounding tissue and become embedded themselves to
form osteoid. Mature osteoblasts found within bone are called osteocytes.
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Figure 2-2: Bone cell types (H&E, courtesy of Dr. Mills)
Osteocytes are oblate star-shaped cells with oblate nuclei and deep staining. The
cytoplasm is weakly basophilic. The human body of adults has about 42 billion
osteocytes [25,26]. Osteocytes do not divide, with an average lifespan of 25 years.
Osteocytes are sandwiched between two adjacent bone plates or distributed within the
bone plates. Gap junctions are present between adjacent bone cells. In the bone matrix,
the oval-shaped cavity surrounded by the cell body of the osteocytes is called a lacuna,
and the surrounding osteocyte filopodia are call canaliculi. Adjacent bone pits are
connected to each other by bone tubules which contain interstitial fluid from which bone
cells get nutrients.
Osteoprogenitor Cells
Osteogenic cells are stem cells present in bone tissue. The cells are spindleshaped, the cell body is small, the nucleus is oval, and the cytoplasm is weakly
basophilic. Osteoblasts exist during the period of bone growth and development, or
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during bone remodeling or bone tissue repair in adulthood. They can divide, proliferate,
and differentiate into osteoblasts.
Osteoclasts
Osteoclasts are large, multi-nucleated cells with a diameter of up to 100 μm and 2
to 50 nuclei. Osteoclasts are derived from the monocyte-macrophage cell line. They have
a strong eosinophilic cytoplasm. It is multinucleated. The cytoplasm at the base is rich in
lysosomes and vesicles.
2.1.3

Bone Repair and Regeneration
Bone healing occurs in three distinct but overlapping stages: the early

inflammatory stage, the repair stage, and the late remodeling stage [27,28]. In the
inflammatory stage, inflammatory cells (macrophages, monocytes, lymphocytes, and
polymorphonuclear cells) and fibroblasts infiltrate the bone under prostaglandin
stimulation and results in the formation of granulation tissue, ingrowth of vascular tissue,
and migration of mesenchymal cells [29].
In this process, the exposed cancellous bone and muscle provide the primary
nutrient and oxygen supply [29]. Interleukin 6 (IL-6) promotes differentiation of
osteoblasts and osteoclasts [30]. Fibroblasts lay down a stroma that supports vascular
ingrowth during the repair stage [29]. Osteoid is secreted and subsequently mineralized
while the collagen matrix is laid down, which leads to the formation of a soft callus
around the repair site [31]. After the collagen matrix of hyaline cartilage or woven bone
becomes mineralized, the lamellar bone begins forming. Then numerous osteoblasts are
recruited and form new lamellar bone upon the recently exposed surface of the
mineralized matrix. During the remodeling stage, bone healing is completed [29]. The
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healing bone is restored to its original shape, structure, and mechanical strength [29].
Remodeling of the bone occurs slowly over months to years and is generally laid down
where it is needed under the influence of mechanical loads [29].
2.2

Overview of Bone Tissue Engineering

Fractures and segmental bone defects are a large economic burden to the
healthcare system due to their high rate of occurrence [32]. Bone grafts, tumors, and
other pathologies are extremely costly furthering the economic burden, for example,
treatment for bone defects is estimated to cost $5 Billion annually in the United States
alone [32].
Bone tissue can naturally heal small bone defects, such as cracks and some types
of fractures. However, bone defects that exceed 2 cm, depending on the anatomical site,
will not heal by themselves [33-35]. Currently, the gold-standard treatment for large bone
defects uses biologically inert metallic devices, bone autografts, and allografts [36,37].
However, metal bone-fixation devices are invasive and will require a second surgery to
remove, bone allografts on the other hand run the risk of disease transmission from
contaminated donor material as well as additional morbidity associated with healing of
the donor site [38]. Bone tissue engineering provides another option for bone
regeneration at the defect site without incurring these risks [39]. Bone tissue engineering
is an interdisciplinary field that uses cells, biocompatible materials, and suitable
biochemical factors toward the development of biological substitutes that restore,
maintain, or improve bone tissue function [38]. Advances in materials science and
understanding of bone biology and structure have allowed for the design of more
sophisticated materials for use in bone-tissue engineering [38]. The goal of bone tissue
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engineering is to introduce specialized materials to a bone defect and then allow the
patient’s cells to heal the defect [38]. These materials are seeded into a scaffold, which is
used as a support structure for cellular adhesion and deposition of the mineralized matrix
[38]. The scaffold is meant to temporarily replace the ECM in redeveloping the tissue
[38].
2.3

Bone Tissue Engineering – State of The Art

A large variety of material types and combinations are promising for bone tissue
engineering [38]. Since the composition of natural bone tissue is both organic and
inorganic, polymers, bioceramics, and composite materials become the most common
biomaterials used for bone-tissue-engineering [38]. Polymers are organic materials. They
are formed from long chains of covalently bonded atoms [40]. Both natural—e.g.,
collagen, gelatin, alginate, alginate and gelatin copolymers—and synthetic—e.g., poly(εcaprolactone), poly(l-lactic acid), poly(lactic-co-glycolic acid)—polymers are used
widely in bone tissue engineering. Compared to the natural polymer commonly used in
bone tissue engineering, some of the new polymers, such as silk, are gaining increased
attention due to their ease of processing, outstanding mechanical properties, and ability to
guide hydroxyapatite formation [41-44]. Examples of such materials are: Poly(propylene
fumarate), a synthetic polymer with similar mechanical properties to the bone,
biocompatible degradation, and ability to photo crosslinking, and poly(Nisopropylacrylamide), a thermoresponsive polymer capable of being copolymerized or
combined with different polymers to produce thermogelling hydrogels [45-47].
Bioceramics are inorganic biomaterials that have been important in bone-tissue
engineering [38]. These materials are generally (crystalline) ceramics, (amorphous)
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glasses, or (partly crystalline) glass ceramics [38]. The most common bioactive ceramic
used for bone-tissue engineering are calcium phosphates because they can mimic the
inorganic phase of bone, carbonated hydroxyapatite [38]. These materials are currently
used in clinical settings as injectable bone cements or coatings for implants [48].
Hydroxyapatite and β-tricalcium phosphate ceramics are two calcium phosphate-based
biomaterials used in bone tissue engineering [38]. Hydroxyapatite is favorable due to its
slow degradation rate, while β-tricalcium phosphate is a resorbable bioceramic [38]. In
large animal models bioceramic granules composed of both calcium phosphates have
been shown to form a mineralized tissue comparable to bone autografts [49]. Bioactive
glasses, another class of bioceramics, are mainly composed of calcium-containing
silicates, however, phosphate and borate derivatives are also in development [38].
Moreover, mesoporous bioactive glasses are attractive multifunctional materials able to
be loaded with various drugs or biomolecules, enabled by their nanoporosity (2–50 nm
diameter) [50,51].
Metals are valued for their high mechanical performance.37 Titanium,
magnesium, and their alloys are the most used metals because they are highly
biocompatible [36,52,53]. Carbon nanotubes [54,55], graphene, and graphene oxide
nanoparticles [56-63] are attractive biomaterials in bone-tissue-engineering due to their
exceptional mechanical properties and large surface areas which facilitate non-covalent
interactions with physiological ions and biomolecules.
Composite biomaterials are promising biomimetic solutions to overcome
substantial challenges in the field of bone-tissue-engineering regardless of the composite
nature of bone and the complexity of the material specifications [38]. The most common
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types of filler composites in bone-tissue engineering are bioactive ceramic and glass
particles [64-69]. Nanoparticulate fillers can be exploited to add greater functionality to
the composites [38]. For example, magnetic iron oxide nanoparticles incorporated in a
PCL matrix and exposed to an external static magnetic field may facilitate enhanced
osteoblastic differentiation and bone formation in the resulting composite [70].
Composites made entirely of particles have been used to develop modular material
systems [38]. These systems are composed of various particle types that act as building
blocks and enable unique properties, such as self-healing [66-71]. Another class of
composite systems is ceramic–matrix or glass–matrix composites [38]. Bioceramic β‐
tricalcium phosphate scaffolds can be coated with graphene oxide nanosheets, which
endow the scaffold with improved osteogenic capacity and photothermal properties that
enables the deactivation of residual bone tumor cells via light therapy [62].
In addition, fabrication technology influences a wide range of biomaterial
properties, from morphological (for example, pore architecture) to physicochemical (such
as degradation), mechanical (such as compressive modulus), and biological (such as cell
infiltration) [38]. Materials can be fabricated into microparticles, nanoparticles [52,7480], fibres [81-88], coatings [68,78,89-91], films [65,68,92,93], and 3D constructs
[34,47,61,69,84,94-111] to fit a specific need or design requirements. Two major
technologies are used for fabrication, 3D printing, and electric-field-assisted techniques.
The forms of 3D printing used for bone-tissue-engineering materials are generally
extrusion, stereolithography, selective laser sintering, and inkjet printing [38]. Several
biomaterial fabrication techniques use an electric field to form particles, fibers, coatings,
films, and 3D constructs, the most common of which is electrospinning [38].
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Electrospinning uses an electric field applied between a syringe and a collector to form
microfibers and nanofibers [112]. New techniques are in development that combine an
electrical area with other fabrication principles [38]. For example, an electrical field can
be applied in an inkjet printing set-up to enable 3D printing via deposition of hydrogel
microdroplets [113]. Another example of this approach is the use of a computercontrolled moving collector and syringe to ensure precise layer-by-layer deposition of
predesigned fiber patterns to produce a 3D construct [114].
Another electric-field-assisted method that has been explored is electrospraying,
which is harnessed to manufacture particles [115] or coatings [116]. Electrophoretic
deposition (EPD) is used to fabricate coatings or films derived from particulate
biomaterials [38].
2.3.1

Hydrogels
Hydrogels are hydrophilic materials that can be of either natural or synthetic

composition [117]. Normally, hydrogels swell when exposed to a large amount of water,
but they do not dissolve [118]. In this way, they resemble loose connective tissue.
Hydrogels have been classified in various ways, typically based on their bonds, and can
be grouped as either physical hydrogels or chemical hydrogels [119,120]. Physical
hydrogels form through the application of physical forces, such as electrostatic
interactions, hydrogen bonding, and chain twining [121]. Physical hydrogels do not have
permanent junctions and heating the hydrogel can cause it to transform into a liquid.
Chemical hydrogels are three-dimensional network polymers that are cross-linked
through the formation of covalent bonds. Compared to physical hydrogels, chemical
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hydrogels form permanent constructs, which means they will not transform into a liquid
[121].
Hydrogels can also be classified into two groups based on their source: natural
polymer hydrogels and synthetic polymer hydrogels [118]. Natural polymer hydrogels,
obtained from natural sources, include gelatin, collagen, chitosan, alginate, agarose fibrin,
and hyaluronic acid [122]. Natural polymer hydrogels are either composed of the native
extracellular matrix (ECM) or have macromolecular properties similar to a natural ECM
[122]. Although the natural polymer material is less stable and biodegrades readily, it has
better biocompatibility, greater environmental sensitivity, lower cost, and better
availability. These benefits have led to increased research on natural hydrogels.
Synthetic polymer hydrogels include such examples as poly(ethylene oxide)
(PEO), poly(vinyl alcohol) (PVA), poly(acrylic acid) (PAA), poly(propylene fumarateco-ethylene glycol) (P(PF-co-EG)), and polypeptides [122]. Synthetic polymers can be
modified to have specific molecular weights, block structures, degradable linkages, and
cross-linking properties [122]. The manipulation of these properties makes synthetic
polymers’ chemical properties and mechanical properties controllable, and reproducible
[122]. Synthetic polymers are hydrophobic by nature. Compared to natural polymers,
synthetic polymers are chemically and mechanically more durable [118]. However, the
mechanical strength leads many synthetic hydrogels to have poor biodegradation
properties. Also, during the synthetic hydrogels’ preparation process, toxic residues are
potentially left in the gels. These will be released into the body as the scaffold
biodegrades, which may cause significant tissue rejection.
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Hydrogels, according to their biological responsiveness to external stimuli, can be
divided into two categories - conventional hydrogels and environmentally sensitive
hydrogels. Conventional hydrogels are not sensitive to environmental changes such as
changes in temperature and pH. Environmentally sensitive hydrogels are designed with
controllable responses such as the ability to shrink or expand with changes in external
environmental conditions [118]. Environmentally sensitive hydrogels respond to changes
in the external environment (such as temperature, pH, light, electricity, and pressure) or
minor stimulation. They can produce a corresponding change in the volume transition
[118]. The salient features of such a gel are a significant change in response to the
environment during the swelling process [118]. The use of this stimulus-response may be
applied to such devices as sensors, switches, and other switch-release devices.
Hydrogels can be used in a diverse array of applications including in hygienic
products [123], agriculture [124], drug delivery systems [123,125], sealing [123], coal
dewatering [126], artificial snow [123], food additives [127], pharmaceuticals [128],
biomedical applications [129-130] tissue engineering and regenerative medicines
[131,132], diagnostics [133], wound dressing [134], separation of biomolecules or cells
[135], barrier materials to regulate biological adhesions [136], and biosensors.
2.3.2

Coatings and Films
Coatings are divided into organic, inorganic, and composite and their usage are

determined based on the material they are applied to [137]. Surface coatings on implants
are formed using various technologies, such as electrophoretic deposition, sol-gel
technique, enameling, physical vapor deposition (pulsed lased deposition and pulsed
electron deposition), and magnetron sputtering [138]. The most frequently developed
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inorganic coating for biomaterials (mainly metallic implants) is calcium phosphate (CaP)
(e.g., hydroxyapatite (HA; Ca10(PO4)6(OH)2), TCP, or CaP glass-ceramics) [139]. CaPbased bioactive layers on an implant surface improve osseointegration between the
biomaterial and host tissue [139]. Importantly, the chemical similarities of CaP-based
coatings to natural bone HA enhance the ability of coated biomaterials to provoke an
appropriate host response [140,141]. Moreover, metallic implants benefit extensively
from CaP-based coatings as they can boost corrosion resistance and reduced metal ion
release to the implantation site [142]. Multiple studies have demonstrated that CaP-based
coatings can promote osteoblast attachment, proliferation, and differentiation [139].
Mumith et al. [143] used an in vivo sheep model to demonstrate that SiHA and strontiumsubstituted HA (SrHA) electrochemical coatings improved osseointegration of a Ti–6Al–
4V implant when compared to and uncoated control. Mokkaber et al. [144] developed
CaP coating containing silver (Ag/CaP) through electrochemical deposition on Ti
substrates. The objective of these coatings was to enhance the biocompatibility and
antibacterial properties of the biomaterials implemented in bone regeneration. They
observed that Ag/CaP coating, where silver as deposited as metallic nanoparticles on the
CaP coating, showed no cytotoxicity towards osteosarcoma-derived osteoblast-like cells
(Saos-2 cell line), but also antibacterial activity. Moreover, the biocompatibility of the
coating was confirmed by the well distributed and adhered Saos-2 cells cultured on the
surface of the samples. Other ceramic coatings, such as oxides, piezoelectric and
ferroelectric ceramics, carbides, and zeolites coatings, may also possess great potential to
accelerate bone tissue regeneration [139].
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In a study performed by Huang et al. [145], evaluation of the osteoconductive and
osteoinductive properties of the magnetic iron/polydopamine (Fe 3O4/PDA) coating were
conducted using in vitro (human bone marrow-derived mesenchymal stem cells
(BMDSCs)) and an in vivo (rabbit femoral bone defects) model. The coating was
fabricated through co-deposition of Fe3O4 nanoparticles and PDA on the surface of 3Dprinted porous Ti scaffolds. The Fe3O4/PDA coating supported cell adhesion,
proliferation, and osteogenic differentiation of BMDSCs and enhanced new bone
formation in vivo. Moreover, researchers observed that an applied static magnetic field
resulted in the enhancement of the osteogenic ability of the coating.
Piezoelectric ceramics, such as barium titanate (BaTiO3) [146-148], lead-free
zirconate titanate derivatives—e.g., (Ba,Ca)(Zr,Ti)O3) [149], and lithium tantalate
(LiTaO3) [150], are often chosen as materials to promote bone growth, remodeling, and
regeneration because they are biocompatible and enhance osseointegration. Moreover,
piezoelectric biomaterials may generate a bioelectrical signal that mimics the stressgenerated potentials of natural bone, when exposed to mechanical stress [139]. These
types of biomaterials may also be able to promote bone healing when subjected to
electrical stimulation or ultrasound [151].
Zeolites are crystalline materials with precisely defined pore structure and high
stability [139]. Zeolites have good biocompatibility, antioxidant, antimicrobial, antiapoptotic, and anti-inflammatory activity [139]. These features make zeolites an ideal
coating material for metallic implants [152]. Chen et al. [153] modified a Ti substrate
surface with zeolitic imidazolate framework-8 (ZIF-8). ZIF-8 is a Zn-based metal-organic
framework belonging to nanoporous solid crystals. Hydrothermal and solvothermal
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methods were used to deposit ZIF-8 films with nanoscale and microscale sizes onto Ti
substrates. The nanoporous ZIF-8 film inhibited Staphylococcus growth, demonstrated
good biocompatibility, enhanced ECM mineralization, and increased the expression of
bALP and Runx2 genes in MG63 cells. However, the microporous ZIF-8 film exhibited
cytotoxicity to MG63 cells.
Carbon coatings (in the form of nanocrystalline or polycrystalline diamond,
diamond-like carbon, amorphous carbon, carbon nanotubes, or graphene) have noncytotoxic characteristics and are used as coatings for metallic biomaterials which
provides them with increased biocompatibility [140,154-157]. Rifai et al. [155] showed
that coating a Ti scaffold with polycrystalline diamond promoted attachment and
proliferation of Chinese Hamster Ovarian (CHO) cells and enhanced apatite deposition.
Another promising material used as an inorganic coating on bone implants is boron
nitride (BN) [121]. BN nanotubes are biocompatible and enhance attachment, growth,
and osteogenic differentiation of rat BMDSCs in vitro [158].
Natural and synthetic polymers that are beneficial as coatings for metal and
ceramic biomaterials in bone tissue applications are proteins such as laminin [159,160]
whey protein isolate [161], collagen [162], and BMP-2 [163], all of which are organic
materials. Organic coatings have high cytocompatibility, biodegradability, and may also
prevent metallic implants and ceramic materials from corroding and degrading [164].
Most polymers are highly biocompatible, which makes them ideal for use with
incompatible biomaterials [139]. Moreover, the inherent structure of some polymers can
mimic the microstructural properties of the bone ECM [147]. Zhao et al. [162] studied the
response of murine embryonic fibroblasts (C3H10T1/2 cell line) to polyelectrolyte
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multilayer coatings composed of hyaluronic acid/collagen or chondroitin sulfate/collagen.
Cells cultured on the chondroitin sulfate-based samples had a more elongated
morphology when compared to cells cultured on the hyaluronic acid-based samples.
Thus, demonstrating that the cells adhered better to the chondroitin sulfate/collagen
coating. Also, cells grown on the chondroitin sulfate-based samples exhibited noticeably
higher ALP activity.
Recently the application of composite coating has garnered much interest due to
the potential for it to mimic the natural bone environment and accelerate bone
regeneration [139]. Furthermore, composite coatings may produce a synergetic effect
between two or more coating components [139]. Yu et al. [166] used a biomimetic
coating process to develop Ti–6Al–4V substrates coated with HA and collagen-HA
(Col/HA) composite. They demonstrated that osteoblasts cultured on the surface of the
biomaterial with Col/HA coating displayed a slightly higher cell proliferation rate when
compared to the HA coating. They also showed enhanced cell adhesion and spreading on
the surface of Ti–6Al–4V coated by both HA and Col/HA composite.
2.3.3

Scaffolds
Traditionally, bone grafts have been used to restore damaged bone [149].

However, bone grafts are restricted by size. Currently, more and more synthetic
biomaterials are now being used as bone graft replacements [167]. These biomaterials
were initially selected based on their biomechanical properties [167]. Later scaffolds
were engineered to be biocompatible or biodegradable to reduce harmful effects. Now
scaffolds are designed to induce bone formation, vascularization and reduce infection
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[167]. These scaffolds are often seeded or coated with growth factors (TGFb, BMP, IGF,
FGF, and VEGF), drugs, and cells (e.g., stem cells, pre-osteoblasts).
An ideal scaffold requires the materials to be biocompatible and bioresorbable, to
have a reasonable pore size, and to have similar mechanical properties to the host tissue.
The ideal pore size of a scaffold is at least 100 µm in diameter, which allows successful
diffusion of essential nutrients and oxygen for cell survivability [168]. Previous research
found that the optimum pore size for bone tissue in-growth is 200-350 µm Scaffolds
[169]. Also, scaffolds involving both micro and macro porosities perform better than only
microporous scaffolds [170]. However, porosity reduces the mechanical properties of the
scaffolds and makes consistent reproduction difficult [167]. Currently, polymers,
ceramics, composites, and metals are the primary materials for fabricating scaffolds
[167]. Mechanical properties of bone differ between types from cancellous to cortical
bone [167]. Young’s modulus of cortical bone is between 15 and 20 GPa, and the
Young’s modulus of cancellous bone is between 0.1and 2 GPa [167]. The compressive
strength of cortical bone varies between 100 and 200 MPa, and for cancellous bone
between 2 and 20 MPa [167]. The large variation in mechanical properties and geometry
makes it difficult to design an ‘ideal bone scaffold’ [171].
Another important factor for scaffold design is bioresorbability [172]. An ideal
scaffold degrades with a resorption rate such that the new bone tissue occupies the newly
opened space [167]. The degradation time of a scaffold should be tunable to the specific
need of the individual patient. For example, scaffolds used to repair spinal fusion require
9 months or more to complete the process, while scaffolds for craniomaxillofacial
applications require 3–6 months [167].
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2.4

Halloysite Structure and Applications

Halloysite nanotubes (HNTs) are naturally occurring aluminosilicate
nanoparticles that have a structure and chemical composition like kaolinite, dickite, or
nacrite [173-175]. HNTs are mined from various mineral deposits making it an easily
accessible nanomaterial. Unlike kaolinite, dickite, or nacrite, the unit layers in halloysite
are separated by a monolayer of water molecules [173-175]. As a result, a hydrated
halloysite has a basal (d001) spacing of 10 Å which is approximately 3 Å larger than that
of kaolinite. Halloysite-(10 Å) can readily and irreversibly dehydrate to give the
corresponding halloysite-(7 Å) form [176] when halloysite-(10 Å) is heated to 90-150 °C.
HNTs can be wildly found in China, France, Belgium, New Zealand, America, and Brazil
[177-181]. The chemical composition for halloysite-(7 Å) and halloysite-(10 Å) is
Al2Si2O5(OH)4٠nH2O where n = 0 and 2, respectively [177,182,183]. If n is 2, the HNTs
are hydrated, and if n is 0, the HNTs are dehydrated [182,183]. AIPEA Nomenclature
Committee recommended terms halloysite-(10 Å) for the hydrated mineral and
halloysite-(7 Å) for the dehydrated form.
The particles of halloysite can adopt a variety of morphologies, the most common
of which is the elongated tubule (Figure 2-3). However, short tubular, spheroidal and
plate particle shapes have all been widely reported [185-192]. Spheroidal halloysite
occurs widely. The diameter ranges of spheroidal halloysite are from 0.05 to ~0.50 mm
[190,193,194]. It is common to find pseudo-spherical or spheroidal particles in weathered
volcanic ashes and pumices [190,191,193-201].
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Figure 2-3: The structure of HNTs and their potential for surface modification [184].
The predominant form of HNTs is a hollow tubular structure in the
submicrometer range. The tubules may be extended and thin, short, and stubby, or
emerging from other tubes [186,190,195,198,202-208]. The halloysite tubules' size varies
from 500-1000 nm in length with an outer diameter of 10-50 nm and an inner diameter
measuring 5-20 nm depending on the deposit [182,183]. The neighboring alumina and
silica layers, and their hydration layers, create a packing disorder causing them to curve
and roll up, forming multilayer tubes. The HNT external surface is comprised of O-Si-O
bonds with terminal hydroxyl groups [177,182,183]. The inner lumen consists of O-Al-O
bonds, terminating in hydroxyl groups [177,182,183]. At pH 8.5 and below, these inner
hydroxyl groups are mostly protonated, resulting in a positive charge on the inner lumen
[177,182,183].
A wide range of active agents, including antibiotics, cancer drugs, marine
biocides, and biological molecules, can be entrapped within the inner lumen and void
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spaces within the aluminosilicate shells [209]. HNTs nanotubes are non-cytotoxic on
several cell types (up to concentrations of 0.1 mg/mL), including chondrocytes, dermal
fibroblasts, osteoblasts, and stem cells on halloysite nanofilms or within HNT-hydrogel
composites [210,211]. Examination of halloysite with in-vitro assays showed cells
proliferated and maintained their cellular phenotype. Several recent biocompatibility
studies have shown that HNTs do not provoke a cytotoxic response or a host immune
response [212,213]. As halloysite nanotubes exhibit high biocompatibility levels and
exceptionally low cytotoxicity, they represent an ideal candidate for new drug delivery
and polymer systems.
2.4.1

Halloysite–Drug Delivery
HNTs have been used as a drug delivery carrier for many clinically meaningful

drugs [17]. HNT can be loaded with different drugs, including anticancer drugs,
antibiotics, analgesics, antihypertension, anti-inflammatory drugs, and therapeutic nucleic
acids [18]. HNTs have been used for the controlled release of antibiotics, including
tetracycline, ofloxacin, norfloxacin, amoxicillin, and ciprofloxacin [18]. Amoxicillin
(AMX) loaded HNT is incorporated into a polylactic acid-glycolic acid copolymer
(PLGA) solution, which is electrospun with water-soluble chitosan nanofibers in two
different syringes simultaneously, thereby making a composite material [214]. Compared
to loading the drug directly into the polymer matrix, HNT extends the release time of
AMX and reduces the initial burst release [214].
Analgesic drugs and anti-inflammatories such as ibuprofen (IBU), diclofenac
sodium, and aspirin have low water solubility and low bioavailability, which are
universal problems [18]. Therefore, the development of an efficient drug delivery system
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by encapsulating drugs in a nanoparticle system for enhancing their bioavailability is an
urgent necessity [18]. 3-aminopropyltriethoxysilane (APTES) functionalized surface
HNT as a carrier for IBU could promote the loading of IBU [215]. By restriction of the
APTES oligomerization in the lumen, free lumen space was preserved and resulted in a
25.4% greater loading rate than that in unmodified halloysite [215]. To sustain greater
release of IBU, an ideal hydrophobic sustained-release drug delivery system was
designed [216]. The preparation combined the techniques of enlarging the HNT lumen
(EHNT) and hydrophobic modification of the external surface by Organosilane (OS)
[216]. The OS composite EHNT demonstrated a sustained-release performance for IBU
(100 h) [216]. Other drug delivery systems such as halloysite–based anti-hypertension
drug- delivery system, and halloysite-based gene therapeutic agent delivery system.
Polydopamine was used to cap HNT for controlled release [217]. After dispersion in a
sodium alginate matrix, and crosslinking via Fe3+, the nanocarrier is used for the delivery
of Diltiazem hydrochloride, which is heavily used in high blood pressure therapy [217].
In gene therapeutic agent-delivery systems, HNTs were surface-modified with γaminopropyltriethoxysilane and assembled with antisense oligodeoxynucleotides
(ASODNs) [218]. These functional HNT complexes improved intracellular delivery
efficiency and inhibited the tumor growth activity of ASODNs [218].
2.4.2

Halloysite–Tissue Engineering
HNTs have a variety of applications in the field of tissue engineering. They are

used in bone implants, dental fillings, and tissue scaffolds [218]. HNT mixed with bone
cement and used as a drug carrier and release system is one of the most common
applications. HNTs loaded with the antibiotic gentamicin sulfate with a concentration of
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5 to 8 wt% in the cement (PMMA) provided sustained release up to 400 h [220]. This
PMMA/halloysite/gentamicin composite tensile strength does not deteriorate as
compared with pure cement and its adhesion to bone is significantly increased [220].
HNTs resin-dentin bond is similar to halloysite-PMMA bone cement [221]. HNT and
functionalized HNT both improved mechanical properties significantly [221-223]. Silver
nanoparticle immobilized HNT (HNT/Ag) fillers significantly improved mechanical
properties [224]. This filler also showed significant antibacterial activity on S. mutans
[224].
Currently, hydrogel scaffolds are being applied to transplant cells and engineer
nearly every tissue in the body, including cartilage, bone, and smooth muscle [225].
Alginate/halloysite nanotube (HNTs) composite scaffolds compared to pure alginate
scaffolds significantly enhance compressive strength and compressive modulus in dry
and wet states [226]. HNTs increased the scaffold density, decreased the swelling ratio in
water, and improved alginate's thermal stability [225]. The alginate/HNT composite
scaffolds have better cytocompatibility [226]. Chitosan–halloysite nanotubes (HNTs)
nanocomposite (NC) scaffolds have similar results as alginate HNTs composite scaffolds
[227]. Compared to the pure chitosan scaffold, the NC scaffolds exhibited significant
enhancement in compressive strength, compressive modulus, and thermal stability [227].
The chitosan–HNTs nanocomposites were cytocompatible even when the HNTs load was
80% [227].
2.5

Strontium Structure and Applications

The element strontium (Figure 2-4) was discovered around 1790 in a mine near
the Scottish village Strontian and was isolated 1808 [229]. Sr is an alkaline earth metal. It
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never occurs on its own in nature, because metallic Sr oxidizes easily forming yellowishcolored strontium oxide [229]. Sr is a soft, silver-white, shiny, and highly conductive
metal. When Sr is burned it produces a red flame. There are four stable isotopes of 84Sr
(0.56%), 86Sr (9.86%), 87Sr (7.02%), and 88Sr (82.56%) [229]. Strontium is the second
least abundant alkaline earth metal. The main ores in which strontium exists are celestite
(SrSO4) and strontium carbonate (SrCO3) [229]. Celestite is mainly used to make SrCO3.
Because strontium carbonate can produce other Sr compounds, it is used to purify Zn
(removing Pb and Cd) for making permanent ceramic magnets, and it is the most
important Sr compound for making TV screens. Sr(NO3)2 is used in pyrotechnic devices,
SrO is used in aluminum smelting, Sr and SrCl2 are used to repair teeth, and Sr(OH)2 has
long been used in the purification of molasses.

Figure 2-4: Structure of Sr and Sr metal [228].
The human body mainly acquires strontium via food and water and is absorbed in
the digestive tract and excreted in the urine. The small intestine has two absorption
mechanisms for strontium: active transport and passive diffusion. The bones hold 99.1%
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of the strontium in the body and only 0.7% in the extracellular fluid [230]. Strontium
regulates the differentiation of MSCs (mesenchymal stem cells) into osteoblasts and
promotes synthesis and precipitation of bone matrix proteins [231]. Therefore, strontium
is a strong promoter of osteoblast differentiation and bone formation. The coordinated
interaction between osteoblasts and osteoclasts is key to the regulation of bone regrowth
and maintaining the stability and integrity of bones [232]. Strontium has at least two
mechanisms for increasing the proliferation of pre-osteoblasts and pluripotent stem cells
[233,234]. In addition strontium improved bone metabolism, prevented bone loss, and
improved bone quality in osteoporotic animals [235]. In bones, strontium can replace a
small amount of calcium in calcified tissue and tooth hydroxyapatite crystals [236]. An
appropriate amount of strontium can improve the mechanical properties of bone and lead
to an obvious increase in hardness [237].
2.5.1

Strontium and Bone Tissue Engineering
Strontium–hardystonite–gahnite (Sr–HT-gahnite; Sr–Ca2ZnSi2O7–ZnAl2O4)

bioceramics have been regarded as important for bone reconstruction because their
elemental composition and mechanical strength are similar to cancellous bone [238].
Wang et al. prepared porous Sr–HT–gahnite bioceramics and investigated them as
carriers for adipose-derived stem cells (ASCs) [239]. They selected these materials to
take advantage of osteogenic activity and angiogenic stimulation of the calcium silicatebased bioceramics. In a critical-sized calvarial bone defect model in rats, the synergistic
effect of the Sr–HT–gahnite/ASCs composite facilitated osteogenesis, angiogenesis, and
vascularized bone formation in vivo.
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Extended release of silicon (Si) ions from calcium silicate-based ceramics into the
microenvironment augments osteogenic activity [240]. Xu et al. synthesize 3D porous
strontium zinc silicate (SZnS, Sr2ZnSi2O7) scaffolds and assessed their in situ mineralized
layer (carbonated calcium phosphate) formation potential using the sponge impregnation
technique [241]. In vitro cell behavior and in vivo bone formation on radial bone defects
were used to establish that scaffolds with a mineralized layer arrested the initial burst of
ions and considerably improved the cell adhesion over a mineralized layer-free scaffold.
Calcium phosphate-based ceramic biomaterials are structurally like natural bone;
however, their low bioactivity limits their clinical use [238]. Ehret et al. doped the
material with Sr ions and optimized the content of hydroxyapatite (HA) in a natural
polysaccharide–hydroxyapatite matrix to promote bioactivity [242]. Implantation of 30%
HA to polysaccharides ratio (w/w) showed considerable improvement on ectopic bone
tissue mineralization in the ectopic site of mice. Both in vitro and in vivo results revealed
partial replacement of calcium in HA by Sr-enriched tissue mineralization, osteoid, and
new blood vessel formation.
Although a variety of natural and synthetic polymers have been used to develop
synthetic implant scaffolds, only a few have had success when implemented for bone
tissue engineering [243]. They are disadvantaged by inadequate biomechanical properties
and biodegradation rate [243]. Ceramics and/or growth factors are applied to polymer
scaffolds to overcome these issues [238]. Recently, a novel nanobiocomposite was
developed by reinforcing a collagen (Col) scaffold with strontium-graphene oxide (SrGO) for large bone defect reconstruction [244]. Incorporation of Sr-GO improved cell
adhesion, osteogenic differentiation, and in vitro tube formation of endothelial cells in the
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scaffold. The resultant bone repair and defect bridging after 12 weeks of transplantation
indicated the potential of the Sr-GO-Col scaffolds for repairing critical-size calvarial
defects in rats. These results were due to the synergistic contribution of GO and Sr in the
MAPK signaling mechanism. It was concluded that Sr-GO-Col scaffolds facilitate
favorable environmental conditions for promoting bone regeneration. PCL is a
biocompatible polymer scaffold with good mechanical properties [238]. An SrCl2 and
PCL coating was used to improve the performance of porous calcined porcine bone
(CPB) [245]. The positive impact of incorporated Sr and PCL on cell responses and bone
reconstruction was demonstrated when a considerable increase was found in the in vivo
bone formation outcome of CPB/PCL/Sr scaffold when compared to CPB and CPB/PCL.
In conclusion, Sr is a safe and effective doping material for stimulating bone
formation and regrowth. Its effectiveness may be more pronounced and variable over
time depending on the concentration applied. It is important to develop adequate models
and form consistent guidelines for research in future studies to better define the
therapeutic application of this element.
2.5.2

Strontium-Coated HNTs and Bone Tissue Engineering
The development of orthopedic implant materials which promote osseointegration

and reduce bacterial infection has gained considerable attention recently [15]. These
implants are being developed to avoid long-term complications. A study reports the
electrodeposition of strontium-halloysite nanotubes (Sr-Hal)/lanthanum, cerium
substituted hydroxyapatite (La,Ce-HAP) composite coatings on titanium surface with
varying Sr-Hal concentrations at 1, 2, and 3 wt%.15 The results of the said study showed
that the mechanical properties of the composite coatings were improved by the
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incorporation of Sr-Hal. The anti-corrosion properties of the Sr-Hal/La,Ce-HAP
composite-coated Ti with 3 wt% Sr-Hal were found to be excellent compared to the other
wt%s. The antibacterial, anti-cancer, and cell viability study of Sr-Hal/La,Ce-HAP
composite coatings revealed antibacterial effects, osteosarcoma cell growth impediment,
and a higher number of viable cells.
Among strontium-based drugs, Strontium ranelate (SrR) is a divalent strontium
salt of ranelic acid which improves the bone microarchitecture [246]. However, some
findings reveal that the SrR negatively affects cell proliferation and osteoblastic
differentiation, depending on its concentration [246]. The incorporation of halloysite
nanotubes (HNT) as nanocarriers of SrR, into gelatin (GN) coatings, tailors the release of
this anabolic bone-forming and anti-catabolic agent [246]. The results showed that 100%
SrR was slow-released in phosphate-buffered saline (PBS) within 21 days. The
nanocomposite coatings confirmed the ability of these composite coatings to enhanced
bone regeneration. Boraei et al. introduced a gelatin- HNT nanocomposite scaffold into
SrR via oral and systemic administration [247]. The mean pore size, porosity, and water
absorption, and mechanical properties of gelatin scaffolds can be increased by adding
HNTs, especially after SrR incorporation. The presence of SrR effectively improved the
proliferation of the MSCs and accelerated osteogenic differentiation. In vivo studies
demonstrated that the SrR released from the Gel/HNTs scaffolds enhanced bone
formation and vascularization.

CHAPTER 3
HNTS AND BMP-2 AS CHEMOATTRACTANTS

3.1

Introduction

Tissue defects are repaired in a series of steps, which include infiltration of host
reparative cells (e.g., osteoblast and fibroblast) into the defect site, the proliferation and
activation of the cells, and the deposition of extracellular matrices (ECMs) in the defects
[248-250]. The rapid recruitment of osteoblasts and bone marrow-derived stem cells to
skeletal defect sites and their proliferation and differentiation is an essential prerequisite
for effective bone repair [248,249]. Several previous studies have used exogenous growth
factors for the recruitment of osteoblasts to the damaged site for a better therapeutic
outcome [250,251]. The delivery of growth factors to the damaged site has become a
widely used methodology that facilitates tissue repair by enhancing host cell recruitment,
proliferation, and activation [7,252]. This approach has shown that faster recruitment of
repair cells to the defect site can significantly reduce the time required for bone tissue
repair and remodeling and can thus enhance bone reconstruction.
For bone repair, BMP-79 platelet-derived growth factor (PDGF) [253],
transforming growth factor-b (TGF-b) [254], insulin-like growth factors, vascular
endothelial growth factor [255], and bone morphogenetic protein-2 (BMP-2) [254,255]
have been used to manipulate cell behavior. Chemotactic cue-induced bone repair
methods can prevent the migration of other types of cells, such as epithelial cells
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[13,256]. However, the utilization of chemical cues still poses several limitations, such as
the high cost of growth factors, the short half-life of growth factor proteins in vivo, and
the potential adverse effects of overdose events or pathological conditions [13,256].
Previous studies in our lab have shown that halloysite nanotubes (HNTs) have an
osteoinductive effect and can induce pre-osteoblasts and stem cells to differentiate into
osteoblasts and produce a mineralized bone matrix [256,257]. The chemotactic potential
of HNTs was the objective of this study.
3.2
3.2.1

Material and Methods

Pre-osteoblast Culture
MC-3T3 E1-subclone4 preosteoblasts (ATCC) were cultured in alpha

modification of Eagle’s medium (α-MEM, Hyclone), which contains 10% FBS and 1%
Pen/ Strep antibiotic (Life Technologies). Cells were cultured in a humidified incubator
at 37 °C and 5% CO2 level.
3.2.2

HNT Chemotactic Potential
To assess the chemotactic response of pre-osteoblasts to HNTs, the cells were

prepared as in Figure 3-1. 24-well migration plates containing a transmembrane insert
were used, with the membrane parallel to the bottom of the well. Control cultures
contained pre-osteoblasts and were not exposed to either HNTs or BMP-2. The
experimental groups received different concentrations of HNTs alone, BMP-2 (without
HNTs) and HNTs doped with BMP-2. A 300 μl cell suspension (serum free) containing
0.5-1x106 cell/ml was placed on the top side of the transmembrane. Then, 500 μl medium
with different concentrations of (1) BMP-2 (1, 5, and 10 ng/ml), (2) unloaded HNTs (50,
100, 250, and 500 μg/ml) and (3) HNTs loaded with BMP-2 (100 μg/ml HNTs with 1, 5,
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and 10 ng/ml BMP-2; 250 μg/ml HNTs with 1, 5, and 10 ng/ml BMP-2) were added to
the lower well of the migration plate. The plates were then incubated for 24 h at 37 °C,
in 5% CO2.

Figure 3-1: Osteoblasts MC 3T3 cell-line (ATCC) were cultured in a 25 cm2 flask as
part of a test of HNTs’ chemotactic potential.
After 24 hours, cotton swabs were used to remove the cells on the top side of the
transmembrane (non-migratory cells). Then, a cell staining solution was used to treat the
cells that had migrated to the bottom side of the membrane (migratory cells) for 10 min at
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room temperature. Next, migratory cells were imaged with a light microscope and
counted with Image J. Afterwards, 200 μl of extraction solution was added to the samples
to remove the dye, and the optical density of the dye solution was measured at a
wavelength of 560 nm in a plate reader.
To further confirm the experimental results, the osteoblasts were stained with
CSFE, the number of migrated cells observed under a fluorescent microscope, and
migrated cells counted (Image J).
3.2.3

Statistical Analysis
One-way ANOVA was used to determine if the number of migratory cells was

significant. Standard error was calculated and indicated as error bars in the figures.
3.3
3.3.1

Results

Histochemical Cell Staining and Cell Counts
The migration cells were stained with cell stain. Figure 3-2 shows cells that

migrated through the membrane under different concentrations (1 ng/ml, 5 ng/ml, and 10
ng/ml) of BMP-2, and different concentrations (50 μg/ml, 100 μg/ml, 250 μg/ml, 500
μg/ml) of HNTs. The 5 ng/ml BMP-2 group had the highest migration rate out of all the
BMP-2 groups. In the HNTs groups, the 100 μg/ml and 250 μg/ml groups had similarly
large migration rates.
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Figure 3-2: Stained cells that migrated through the transmembrane as imaged under
light microscopy. (A) serum free (control), (B) 1 ng BMP-2, (C) 5 ng BMP-2, (D) 10
ng BMP-2, (E) 50 μg/ml HNTs, F. 100 μg/ml HNTs, (G) 250 μg/ml HNTs, (H) 500
μg/ml HNTs.
Then, the BMP-2 was combined with the highest migration rate group of HNTs
and imaged (Figure 3-3). The greatest migration occurred when 100 μg/ml HNTs were
combined with 10 ng/ml BMP-2 and when 250 μg/ml HNTs were combined with 10
ng/ml BMP-2. Bar graphs of the UV absorbance confirmed the results Figure 3-4 shows
the results for different concentrations of HNTs and for different concentrations of BMP2. Figure 3-5 shows the combined effects of HNTs mixed with BMP-2. However, in
Figure 3-2 and Figure 3-3, some cells were stained a darker color than the others, which
means these cells had a higher UV absorbance value that may not be dependent only on
the number of migrated cells, but also on the degree of staining for each cell.
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Figure 3-3: Stained migrated cells under light microscope. 1 ng BMP-2, (A, D (100
μg/ml, 250 μg/ml HNTs)), 5 ng BMP-2, (B, E (100 μg/ml, 250 μg/ml HNTs)), 10 ng
BMP-2. (C, F (100 μg/ml, 250 μg/ml HNTs)).
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Figure 3-4: UV absorbance results among control, 1 ng BMP-2, 5 ng BMP-2, 10 ng
BMP-2, 50 μg/ml HNTs, 100 μg/ml HNTs, 250 μg/ml HNTs, 500 μg/ml HNTs.
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Figure 3-5: UV absorbance results between 100 μg/ml HNTs (blue) and 250 μg/ml
(green) with 1 ng BMP-2, 5 ng BMP-2, and 10 ng BMP-2 separately.
To further confirm which group has a higher migration rate. The number of
migrated cells in each sample was calculated. Figure 3-6 shows the cell counting results
for BMP-2 alone. The 5 ng/ml BMP-2 group shows the highest number of migrated cells
out of all the BMP-2 groups. Figure 3-7 shows the cell counting results for HNTs alone.
The 250 μg/ml HNTs group shows the highest number of migrated cells.
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Figure 3-6: The number of migrated cells when the BMP-2 concentration are 1
ng/ml, 5 ng/ml, 10 ng/ml and 0 ng/ml (control).
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Figure 3-7: The number of migrated cells when the HNTs concentration are 50
μg/ml, 100 μg/ml, 250 μg/ml, 500 μg/ml and 0 μg/ml (control).
Among the BMP-2 with HNTs groups (Figure 3-8), 5 ng/ml BMP-2 with 100
μg/ml HNTs has the highest number of migrated cells, while 5 ng/ml BMP-2 with 250
μg/ml HNTs group and 10 ng/ml BMP-2 with 250 μg/ml HNTs group have the secondhighest number of migrated cells. A one-way ANOVA analysis indicated a significant
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contribution to the variability in migrating cell count for both BMP-2 concentration
(p=0.0029) and HNT concentration (P=0.000018).
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Figure 3-8: The number of migrated cells when the BMP-2 (1 ng/ml, 5 ng/ml, and 10
ng/ml) doped HNTs (100 μg/ml and 250 μg/ml).
3.3.2

Histochemical Cell Staining and Cell Counts

The osteoblasts were stained with CSFE, and the number of migrated cells was observed
under a fluorescent microscope (Figure 3-9) and migrated cells counted (Figure 3-10).
The 5 ng/ml BMP-2 groups had the highest number of migrated cells, and a combination
of 5 ng/ml BMP-2 with 50 μg/ml HNTs had the highest number of migrated cells overall.
Through one-way ANOVA analysis, a significant difference in the number of migrated
cells can be observed among the different concentrations of BMP-2 doped with different
concentrations of HNTs (P=0.000052). This confirmed that the combination of different
concentrations of BMP-2 and HNTs is a crucial factor affecting cell migration.
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Figure 3-9: Stained migrated cells observed under epi-fluorescent microscopy.
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Figure 3-10: Cell counts for BMP-2 and HNTs. This figure shows the number of
migrated cells when the HNTs concentration are 50 μg/ml, 100 μg/ml, 250 μg/ml, and
500 μg/ml combine with 1 ng/ml, 5 ng/ml, and 10 ng/ml BMP-2. (Error bars are
standard deviations, n=3, p<0.05).
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3.4

Conclusions

We found that HNT groups have the highest migration rate when they have a 250
μg/ml concentration. Of the BMP-2 groups, 5 ng/ml BMP-2 showed the most migrated
cells. When HNTs are present in the medium, 5 ng/ml BMP-2 had the highest migration
rate. Especially the group which has 5 ng/ml BMP-2 and 50 μg/ml HNTs. All these
results indicate that the HNTs and HNTs doped with BMP-2 can become a new agent for
use in bone regeneration.
3.5

Discussion

This study aimed to identify the optimal concentration of bioactive agents and
derived composites that provide a better cell-supportive environment. Critical in our
design was to determine if HNTs had a potential chemotactic effect. The preosteoblast's
migration rate in response to different concentrations of HNTs, BMP-2, and HNTs
combined with BMP-2. The medium we used in the transmembrane insert is a serum-free
medium because the traditional medium contains growth factors and proteins that could
affect cell migration. In the lower well, the only difference is the chemicals we added and
their concentrations. In this way, we only need to compare the number of migratory cells;
we can quickly figure out the best chemo attractive agent and the optimal concentration.
However, because the method counts the migrated cells, it is essential to choose the right
cell stain. The first stain that came with the migration assay kit caused uneven staining of
the cells, which affected the UV absorbance and cell counting results. The second
staining agent CSFE solves the problem of uneven staining, which makes our results
more reliable.
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The data shows that pre-osteoblasts migrated in the presence of HNTs. HNTs
doped with BMP-2 showed a greater migration rate in comparison with native HNTs. The
5 ng/ml BMP-2 group showed the highest number of migrated cells out of all the BMP-2doped HNT groups. When HNTs were present in the medium, 5 ng BMP-2 had the
highest overall migration rate, particularly in the 5 ng/ml BMP-2 doped 50 μg/ml HNTs.
These results indicate that HNTs and HNTs dopped with BMP-2 have potential as new
scaffolding osteogenic agents for bone regeneration.

CHAPTER 4
DEVELOPMENT OF A COLLAGEN METHACRYLATE/HNT
HYDROGEL COMPOSITE (COMA-HNT) SYSTEM

4.1

Introduction

Project #1 has established that HNTs and BMP-2-doped HNTs have a
chemoattractive effect on pre-osteoblasts, in the case of BMP-2 doped HNTs the
migration rate was even more pronounced. Osteoblasts regenerate and repair damaged
bone by producing an osteoid matrix and, subsequently, mineralizing it [232]. The bone
repair process was initiated by mobilizing osteoblasts to the site of the damaged bone
[30]. In certain bone disorders, elderly individuals, and some osteogenic disease states,
bone repair, and healing, are prolonged, and frequently completely lacking [232]. The
healing process may be accelerated and enhanced through the rapid recruitment of
osteoprogenitor cells and osteoblasts to the injury site. We hypothesized that HNTs and
BMP-2 doped HNTs would act as a signaling mechanism and recruit osteoblasts (preosteoblasts, stem cells) towards doped HNTs. The recruited cells would proliferate and
differentiate into osteoblasts with enhanced osteogenic gene expression. Local areas of
the mineralized matrix should form following this cascade of events.
Accordingly, the principal goal of Project #2 is to develop a novel nanocomposite,
composed of HNTs, strontium metalized HNTs, doped with osteogenic chemoattractants
and antibiotics, all incorporated into a biocompatible hydrogel (methacrylated collagen).
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Furthermore, our target was to remediate a bone disease (osteomyelitis) while
simultaneously initiating bone tissue regeneration. Our focus was on creating an
antimicrobial and osteogenic nanocomposite. The composite was based on a
methacrylated collagen hydrogel. We used in vitro culture systems to test the following
compositions added to methacrylated collagen (COMA).
1). Strontium coated HNTs (SrHNTs),
2) HNTs,
3). BMP-2-doped SrHNTs (SrB/SrHNTs+BMP-2), and
4). BMP-2-doped HNTs (HB/HNTs+BMP-2).
Osteoprogenitor cells should differentiate in-situ into osteoblasts, and with the
recruited osteoblasts, actively regenerate new bone. Recent studies have indicated a
critical role for various growth factors as chemoattractants (CTs) during the process of
endochondral ossification and fracture repair [9-12]. In many cases, these same CTs also
have a proliferative and differentiative influence on human osteoblasts.
The project produced a composite photo-crosslinked hydrogel with favorable
mechanical properties and tunable bioactive properties. Furthermore, this hybrid hydrogel
system can be regulated to meet specific bone and tissue regeneration applications. In this
study, we determined the optimal combination between different concentrations of
methacrylated collagen and cross-linking time to develop a strength-enhanced
biomaterial that is both biocompatible and biodegradable. This study will help further the
clinical applications of methacrylated collagen scaffolds for bone regrowth and
substitution.
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Methacrylated collagen was prepared in different concentrations (4 mg/ml (4%),
and 8 mg/ml (8%)) and with different cross-linking time (14 min, and 18 min). The
mechanical and cell properties were studied and characterized. We also tested the
material properties and the tissue-forming capabilities by culturing osteoblast/preosteoblasts. The mechanical properties of the methacrylated collagen hydrogel should
provide an idea for future research and application.
4.2
4.2.1

Materials and Methods

Prepare Sr Coated HNTs
We ordered HNTs from Sigma Aldrich and coated them with Sr by adding the

HNTs and Strontium carbonate (SrCO3) from Sigma Aldrich in the same quantities to
distilled water as illustrated in Figure 4-1. A sonicator was used to evenly distribute the
particles and eliminate clumps. The reaction mixture (Rm) was sonicated at regular
intervals for 30 minutes for 3 days. The Rm was kept in an incubator (60 °C). The
precipitate obtained was washed in citric acid (pH=4) to remove excess CO 32- ions and
water-washed 3 times. The precipitate was collected and dried.
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Figure 4-1: Schematic representation of the process to make Green SrHNT.
4.2.2

In Vitro Degradation Assay
An in vitro degradation assay was used to study the weight loss after dehydration

of the samples (n = 3, Figure 4-2). All samples were prepared in a 1.5 ml tube. Then the
solution was transferred to a silicon mold, the length, width, and depth of which was
1553.5 mm. The set volume for each sample was 250 µl. All samples were set in the
mold for 14, and 18 minutes under UV light. The samples were pre-incubated in DPBS at
37 ℃ for 1 day. Then the samples were collected after 1, 7, and 14 days. DPBS was
changed every 3 days. After each specific time point, the samples were rinsed in DPBS,
weighed, and lyophilized using a freeze-dryer for 24 hours. The weight of the dried
samples was determined after lyophilization. The percent degradation for each sample
was calculated as the weight loss from the sample's initial dry weight.
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Figure 4-2: Degradation procedure.
4.2.3

Scanning Electron Microscopy (SEM)
The surface topographies of all samples were examined in a dry condition after

the cross-linking process. A cross-linked group of samples was prepared in a 1.5 ml tube.
Then, the solution was transferred to a small pipe sealed on one side, the diameter of
which is 6.25 mm. 100 µl total volume was removed from all samples. All samples were
set in a pipe for 14, and 18 minutes under UV light. Dry samples were pre-frozen at −20
℃ for 24 hours and lyophilized using a freeze-dryer for 1 day. All samples were coated
with gold. The surface topography of all samples was imaged by SEM (Hitachi S4800).
4.2.4

Contact Angle
Samples were prepared in a 1.5 ml tube. Then, the hot solution was poured onto a

piece of glass. The samples were set on the glass for 24 hours at 21 ℃. Hydrophilic
properties of the developed methacrylated collagen sample were determined by water
contact angle measurement using the static Sessile Drop technique. Contact angles were
measured at 20 seconds and after 80 seconds to observe any changes in the droplets’
shape. The contact angle of the sample was measured using a contact angle system OCA
by Data Physics (San Jose, CA). The average of all measured samples was reported with
its standard error bar.
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4.2.5

Cell Proliferation
Cells were seeded on pretreated scaffolds at a concentration of 1105 cells/ml.

The culture media was changed every 3 days. Cell proliferation was assessed through a
cell proliferation assay. The proliferation data were collected on days 1, 7, 14, and 21
days after the initial cell seeding.
4.2.6

Cell Differentiation
An Osteocalcin Quantikine ELISA kit (R&D system) was employed to measure

osteocalcin (OC) as a marker for osteogenic differentiation. All samples were assessed
for each condition. After cell culture, samples were rinsed with PBS, incubated with 0.2
mL of acetic acid (10% by volume) for 1 h at 37 ℃, and lyophilized overnight. The
manufacturer’s sample buffer was used to resuspend the lyophilized protein before
transfer to the ELISA plate. ELISA plates were processed according to the
manufacturer’s protocols. A standard curve was generated to determine osteocalcin
concentration. Sample measurements with background subtracted were used as controls.
Controls were COMA gel samples incubated with cells in cell culture medium for 21
days (with medium changes) and then assayed by ELISA.
4.2.7

Statistical Analysis
One-way ANOVA was used to determine if the level of degradation,

proliferation, and differentiation was significant. Standard error was calculated and
indicated as error bars in the figures.
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4.3
4.3.1

Results

In Vitro Degradation Assay
In the regeneration of bone, the degradation rate of the scaffold needs to match

the regeneration rate of the bone. The degradation of HNTs/COMA hydrogels was
performed in PBS to mimic conditions in vivo (Figure 4-3). The rate of hydrogel mass
loss showed a significant increase on day 7. The remaining mass of the HNTs/COMA
hydrogels was significantly reduced after being immersed in PBS for 14 days.
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Figure 4-3: In vitro degradation results. (n=3, p<0.05).
In this study, the 4% COMA group degraded faster than the 8% group. In the 4%
COMA group, samples crosslinked for 14 min degraded faster than samples crosslinked
for 18 min. The 8% CoMA group exhibited minimal weight loss. The addition of HNTs
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in 8% COMA groups showed a slight increase in the degradation ratios while the 4%
COMA groups did not show a similar increase in the degradation ratios. As the amount of
HNTs was increased the degradation ratios tended to decrease, though with no significant
differences. A possible reason could be that the incorporation of HNTs may affect the
network of COMA, though the impact on the degradation was limited. The groups
incorporating HNTs, and BMP-2 have a slightly higher degradation ratio than other
samples in their groups.
4.3.2

SEM
The COMA gel was imaged at two concentrations and two crosslinking times

(four combinations). The SEM images were acquired to study the surface features of each
condition. Samples were pretreated by lyophilization and coated with 6 nm gold.
Figure 4-4 shows SEM images for 8% COMA gel crosslinked for 18 min. The
8% 18 min COMA gel group, gel with additional SrHNTs and BMP-2, and HNTs and
BMP-2 showed clear collagen fiber on the surface. The thickness of the collagen fibers
on SrHNTs and BMP-2, and HNTs and BMP-2 are approximately the same. Instead, the
SrHNTs, HNTs, and control (COMA) hydrogel have a smooth exterior. The HNTs
sample has the smoothest surface and some noticeable cracks.
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Figure 4-4: SEM results for 8% COMA gel that was crosslinked for 18 min. (A)
SrHNTS+BMP-2, (B) HNTs+BMP-2, (C) SrHNTs, (D) HNTs, (E) COMA.
In the 8% 14 min COMA gel group (Figure 4-5), gel with additional SrHNTs and
BMP-2, SrHNTs, and HNTs showed truly clear collagen fiber on the surface. Compared
to SrHNTs and BMP-2, and SrHNTs, gel with HNTs has less fiber and a smoother
surface. The thickness of the collagen fibers on SrHNTs and BMP-2 is thicker than the
fiber on SrHNTs. Instead, the HNTs and BMP-2, and control hydrogel have a smooth
exterior. The HNTs and BMP-2 sample has barely any fibers.
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Figure 4-5: SEM results for 8% COMA gel that crosslinked for 14 min. (A)
SrHNTS+BMP-2, (B) HNTs+BMP-2, (C) SrHNTs, (D) HNTs, (E) COMA.
In the 4% 18 min COMA gel group (Figure 4-6), all gels have a smooth exterior.
Gels with additional SrHNTs showed obvious collagen fibers on the surface. Compared
to SrHNTs, gel with SrHNTs and BMP-2, HNTs, and control has less fiber and a
smoother surface. The thicknesses of the collagen fibers on all the samples are
approximately the same.
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Figure 4-6: SEM results for 4% COMA gel that are crosslinked for 18 min. (A)
SrHNTS+BMP-2, (B) HNTs+BMP-2, (C) SrHNTs, (D) HNTs, (E) COMA.
In the 4% 14 min COMA gel group (Figure 4-7), all gels have clear collagen
fiber on the surface. COMA gel has less fiber and a smoother surface. The thicknesses of
the collagen fibers on all the samples are approximately the same. The SrHNTs and
BMP-2, and SrHNTs hydrogel have more collagen fiber than the other samples.
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Figure 4-7: SEM results for 4% COMA gel that was crosslinked for 14 min. (A)
SrHNTS+BMP-2, (B) HNTs+BMP-2, (C) SrHNTs, (D) HNTs, (E) COMA.
When all the combinations are compared, 4% 14 min COMA gels generally have
a rougher exterior, while 4% 18 min COMA gels have a smoother exterior. Samples
containing SrHNTs and HNTs are rougher than the control.
4.3.3

Contact Angle
Biomaterials for implanting the bone should evoke favorable cellular responses in

cell attachment, adhesion, proliferation, and differentiation. In particular, the initial phase
of cell/material interactions and the quality will influence the cell’s capacity to proliferate
and differentiate. Generally, when the contact angle decreased, the cell adhesion
increased. In this study, type I collagen was used because it facilitates cell attachment and
enhances surface bioactivity. In this study, the contact angle was measured at 20 seconds
and 80 seconds to determine if there was a change in the droplets’ shape.
In the SrHNTs and BMP-2 groups (Figure 4-8), 8% COMA hydrogels had a
larger contact angle than 4% COMA hydrogels, which indicated 8% COMA hydrogels
were more hydrophobic than 4% COMA hydrogels. When compared to the 8% and 4%
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groups, COMA hydrogels crosslinked for 14 min had smaller contact angel than COMA
hydrogels crosslinked for 18 min, which indicated COMA hydrogels crosslinked for 14
min were more hydrophilic than the 18 min samples. All samples’ contact angles reduced
as time went up.
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Figure 4-8: SrHNTxBMP-2 contact angle results. (Error bars are standard deviations,
n=3)
In the HNTs and BMP-2 groups (Figure 4-9), 8% COMA hydrogels had a larger
contact angle than the 4% COMA hydrogels, except for the 4% 18 min COMA hydrogel
at 20 seconds, which indicated 8% COMA hydrogels were generally more hydrophobic
than 4% COMA hydrogels. Compared to the 8% and 4% groups, COMA hydrogels
crosslinked for 14 min had smaller contact angles than COMA hydrogels crosslinked for
18 min, which indicated COMA hydrogels that crosslinked for 14 min were more
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hydrophilic than 18 min samples. All samples’ contact angle decreased as time after drop
placement increased.
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Figure 4-9: HNTxBMP-2 contact angle results. (Error bars are standard deviations,
n=3)
In the SrHNTs groups (Figure 4-10), 8% COMA hydrogels had a larger contact
angle than 4% COMA hydrogels, which indicated 8% COMA hydrogels were more
hydrophobic than 4% COMA hydrogels. Within the 8% and 4% groups, COMA
hydrogels that crosslinked for 14 min had smaller contact angel than COMA hydrogels
that crosslinked for 18 min, which indicated COMA hydrogels that crosslinked for 14
min were more hydrophilic than 18 min samples. All samples’ contact angle reduced as
time went up.
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Figure 4-10: SrHNT contact angle results. (Error bars are standard deviations, n=3)
In the HNTs groups (Figure 4-11), 8% COMA hydrogels had a larger contact
angle than 4% COMA hydrogels, which indicated 8% COMA hydrogels were more
hydrophobic than 4% COMA hydrogels. Within the 8% and 4% groups, COMA
hydrogels that crosslinked for 14 min had smaller contact angel than COMA hydrogels
that crosslinked for 18 min, which indicated COMA hydrogels that crosslinked for 14
min were more hydrophilic than 18 min samples. All samples’ contact angle reduced as
time went up.
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Figure 4-11: HNT contact angle results. (Error bars are standard deviations, n=3)
In the control groups (Figure 4-12), 8% COMA hydrogels had a larger contact
angle than 4% COMA hydrogels, except the 8% 14 min COMA hydrogels. Within the
8% and 4% groups, COMA hydrogels that crosslinked for 14 min had smaller contact
angel than COMA hydrogels that crosslinked for 18 min, which indicated COMA
hydrogels that crosslinked for 14 min were more hydrophilic than 18 min samples.
Within the 4% groups, no significant difference was found in contact angle between the
samples that crosslinked for 14 min and 18 min. All samples’ contact angles decreased
with time.
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Figure 4-12: Control contact angle results. (Error bars are standard deviations, n=3)
Figure 4-13 shows contact angles for all the cases studied. The SrHNTs 4% 14
min COMA hydrogel had the smallest contact angle at 80 seconds. SrHNTs and BMP-2
4% 14 min COMA hydrogel had the second smallest contact angle at 80 seconds.
Overall, the hydrogels with a proper percent of COMA gel and crosslinking time tended
to have improved hydrophilic properties, indicating the potential to improve bone
regeneration in vivo.
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Figure 4-13: Contact angle results. (Error bars are standard deviations, n=3, p<0.05)
4.3.4

Cell Proliferation
The MTS results showed no differences among each group on day 7 (Figure

4-14) except for 8% 18 min crosslinking groups, which were significantly higher than the
other groups on day 7. On day 14, the cells treated with HNTs/COMA 4% hydrogels
presented a higher proliferation rate than the 8% groups, indicating that a specific
concentration of COMA may benefit the proliferation of preosteoblasts at an early stage.
On day 21, the group treated with SrHNTs, and HNTs COMA 8% 14 min hydrogel
showed a lower proliferation rate than other groups with HNTs. On day 28, all samples
showed a similar proliferation rate.
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Figure 4-14: Cell proliferation results. (Error bars are standard deviations, n=3,
P>0.05)
4.3.5

Cell Differentiation
Osteocalcin is another indicator of osteogenic differentiation since it is secreted

only by osteoblasts. Osteocalcin was quantified on day 7, day 14, and day 21. The
osteocalcin results showed no differences among each group on day 7 (Figure 4-15). On
day 14, the cells treated with SrHNTs and BMP-2 COMA 18 min hydrogels and HNTs
and BMP-2 COMA 4% 18 min hydrogel presented a higher differentiation rate than other
groups. On day 21, the cells treated with SrHNTs, and BMP-2 COMA 4% 18 min
hydrogels presented the highest differentiation rate compared to other groups. Therefore,
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results demonstrated that SrHNTs and BMP-2 COMA 4% 18 min hydrogels enhanced
preosteoblasts differentiation and osteogenesis in vitro.
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Figure 4-15: Cell differentiation results. (Error bars are standard deviations, n=3)

4.4

Conclusions

In the degradation study, the 4% COMA group degraded faster than the 8%
group. In the 4% COMA group, samples crosslinked for 14 min degraded faster than
samples crosslinked for 18 min. The contact angel results show that SrHNTs 4% 14 min
COMA hydrogel had the smallest contact angel at 80 seconds. SrHNTs and BMP-2 4%
14 min COMA hydrogel had the second smallest contact angle at 80 seconds. All
samples showed a similar proliferation rate. The differentiation results demonstrated that
SrHNTs and BMP-2 COMA 4% 18 min-crosslinked hydrogels enhanced preosteoblasts
differentiation and osteogenesis in vitro.
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4.5

Discussion

The objective of this project is to determine the optimal combination of different
concentrations of methacrylated collagen, HNTs/ SrHNTs, BMP-2 doped HNT/SrHNT,
and cross-linking time for use in 3D bioprinting. From project #1 we found 5 ng/ml
BMP-2 doped 50 µg/ml HNTs and 250 µg/ml HNTs have the highest and second-highest
migration rate. Our lab’s previous research found Sr helps bone repair. We added
SrHNTs to see if the same amount of SrHNTs works better than the HNTs in the COMA
gel composite system.
The objective of the degradation study was to determine whether the concentration or
crosslinking time of COMA gel affected its degradation. The degradation test gives us a
general idea of how long our material could last in an animal body. Our research found
degradation time increased if COMA gel concentration increased. Our research also
found when COMA gel crosslinking time increased, degradation time increased. Besides
UV light crosslinking, we also can add genipin which is a naturally occurring crosslinking agent that has significantly low toxicity to increase crosslinking levels. This is
another way to increase degradation time. However, this does not mean the longer the
degradation time, the better. Its duration depends on how quickly the patient's wound is
repaired. Above all, we can choose the most suitable cross-linking method according to
our specific needs.
The SEM results showed us the surface characterization of our COMA gel. The
samples’ temperature went up before UV crosslink, after crosslinking the COMA gel had
a white color. They had more collagen fibers forming than the gel kept at a low
temperature. The samples kept at a low temperature after crosslinking had clear color.
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Biomaterials for implantation in bones should evoke favorable cellular responses
in terms of cell attachment, adhesion, proliferation, and differentiation. In particular, the
initial phase of cell/material interactions and the quality of this stage will influence the
cell’s capacity to proliferate and differentiate. Generally, when the contact angle
decreased, the cell adhesion increased. In this study, type I collagen was used due to its
excellent properties that facilitate cell attachment as well as enhance surface bioactivity.
In the contact angle test, we found most of our samples had a small contact angle after
80s. It is difficult to measure the contact angle over a longer period.
Since the proliferation test results showed no significant difference, the
ingredients we added did not inhibit cell proliferation. However, the differentiation test
screen out SrHNTs+BMP-2 composited with 4% 18min COMA gel had the highest
differentiation rate. This indicated SrHNTs+BMP-2 composited with 4% 18min COMA
gel repair bone defects faster than the rest of the samples.

CHAPTER 5
3D BONE CELL CULTURE - ASSESSMENT OF COMA-HNT
HYDROGEL COMPOSITE’S ANTI-INFECTIVE/
OSTEOGENIC IN VITRO POTENTIAL

5.1

Introduction

In project #2, we screen out the optimal nanocomposite system for bone repair
and regeneration. However, hydrogels do not have a strong mechanical property.
Repairing bone damage requires the use of materials with high mechanical strength to
print the scaffold. Then we use our nanocomposite materials to modify the surface of the
scaffold to make cell-affinity of the scaffold better. Meanwhile, the scaffold material
must also be degradable. Since bone repair takes several months, when choosing a
scaffold material, the material cannot degrade too fast or too slowly.
On the other hand, bone-related infections have become a significant concern.
Gentamicin is an antimicrobial that wildly used. Minocycline is an antimicrobial that
majority used in dental infections. Our objective in project #3 is to determine the 3D
bioprinted scaffolds’ effectiveness in inhibiting bacterial growth as well as its tissue
regenerative properties.
5.2
5.2.1

Materials and Methods

Material
Polycaprolactone (PCL) filament (eSUN, Shenzhen, China)
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5.2.2

3D Printing
The above materials were 3D printed into the desired structure by a GEEETECH

A10M 3D printer at 185°C. The scaffolds were designed to be 12124 mm with a pore
size of 1.7 mm. The diameter of the inside lattice girders is 0.9 mm (Figure 5-1).

Pore
Lattice Girder

Figure 5-1: 3D printing design. (A) Top view. (B) Trimetric view. (C) Left cut view.
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5.2.3

Coating COMA Gel
The 3D printed scaffolds were sterilized in 75% ethanol for 24 hours, washed

with 0.01 M PBS, soaked into pre-made 4 mg/ml (marked as 4%) COMA gel
(gentamicin+SrHNTs+BMP-2, minocycline+SrHNTs+BMP-2, SrHNTs+BMP-2) and
crosslinking under UV light for 18 min.
5.2.4

Morphology and Surface Characterization
The morphology of 3D printed scaffolds was observed under a laser confocal

microscope. An SEM/EDS was used to observed and analyze the surface of the samples.
EDXRF was used to quantify the amount of Sr in the SrHNTs sample.
5.2.5

Porosity
The porosity of 3D printed scaffolds was calculated via liquid displacement.

Three 3D scaffolds were immersed in 5.0 ml (V1) of DI water, then vortexed and
sonicated to force the liquid into the pores of the scaffolds. The total volume of scaffolds
and DI water was measured (V2). After the water was removed, the scaffolds and the
remaining volume of DI water were measured (V3). Equation 5-1 was used to calculate
the final porosity of the scaffold.
Porosity =
5.2.6

V1 − V3
V2 − V3

Equation 5-1

Compressive Test
A CellScale Unit was used to measure the elastic modulus under compression. 3D

printed samples were compressed with a 200 N load cell. The stress and strain profiles
were measured. The compression modulus was calculated from Equation 5-2
𝜎
𝐸= ,
𝜀

Equation 5-2
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where 𝐸 is the compression modulus, 𝜎 is the applied compressive stress, and 𝜀 is the
strain (compressed length/original length). At least 3 tests were performed for each
sample.
5.2.7

Cell Culture
Pre-osteoblast (MC3T3-E1) cells were seeded into a 3D printed scaffold to

analyze cell differentiation. MC-3T3 E1 (ATCC) were cultured in an alpha modification
of Eagle’s medium (α-MEM, Hyclone) with 10% fetal bovine serum (FBS) and 1%
Pen/Strep antibiotic (Life Technologies). Cells were cultured in a humidified incubator at
37 °C and 5% CO2 level.
5.2.8

Mineralization-Alizarin Red Staining
Matrix mineralization was assessed by Alizarin Red S (ARS) staining. The cells

on the scaffolds were ﬁxed with 99% ethanol for 15 minutes at room temperature, then
stained with 2% ARS for 30 minutes. The samples were washed with DI water 4 times
and digital images of stained scaffolds were acquired under a brightfield microscope.
Cells cultured in the regular 2D condition were used as controls.
To quantify mineralization, 10% acetic acid (Fisher Scientific) was added to the
stained samples under agitation for 30 min, allowing the ARS to leech into the acetic
acid. The ARS-containing acetic acid was collected and neutralized with 10% ammonium
hydroxide (Sigma-Aldrich) until the pH was 4.1− 4.5. The optical density was read with a
Thermo Scientific spectrophotometer at 405 nm.
5.2.9

Picrosirius Red Staining
Picrosirius Red is a specific collagen fiber stain that can detect thin fibers. The

medium was removed from the cell culture plates and washed with DPBS, then fixed in

70
99% ethanol. These cells were stained with Picrosirius Red to quantify the amount of
collagen secreted. Picrosirius stain was added to each well and removed after an hour of
incubation at room temperature. The cells were rinsed with 0.5% acetic acid solution
twice and absolute alcohol twice. Digital images of stained scaffolds were acquired under
a brightfield microscope. Cells cultured in regular 2D conditions were used as controls.
5.2.10

Bacteria Inhibition Study
Escherichia coli (ATCC 35218) and Staphylococcus aureus (ATCC BAA-1026)

were cultured in Luria-Bertani (LB) broth liquid medium. The absorbance of the bacterial
concentration at 630 nm is 0.08-0.1, which corresponds to 1 to 2108 CFU/ml. The
inoculum from the LB broth was plated onto Mueller-Hilton agar plates under sterile
conditions. Control and experimental samples were placed on inoculated plates and were
incubated at 37 °C for 18 hours. After incubation, the plates were measured for inhibition
zones and compared with gentamicin (10 µg) and minocycline (30 µg) antimicrobial
susceptibility disks.
5.2.11

Statistical Analysis
One-way ANOVA or Student T-test was used for statistical analysis. Data were

expressed as mean  standard error. A p-value less than 0.05 was considered statistically
significant.
5.3
5.3.1

Results

Morphology of 3D Printed Scaffold and Surface Characteristics
SEM images are shown in Figure 5-2. The PCL scaffold with no coating has the

smoothest exterior. Gentamicin+SrHNTs+BMP-2 COMA gel-coated PCL and
minocycline +SrHNTs+BMP-2 COMA gel-coated PCL samples have some pores that the
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gel did not enter. All the gel coatings are relatively smooth, except for the
SrHNTs+BMP-2 case, which exhibits air bubbles. These SEM images indicated the gel
coatings are uneven on each scaffold.

Figure 5-2: The SEM images for 3D printed scaffolds. (A)
Gentamicin+SrHNTs+BMP-2 COMA gel-coated PCL sample at 25× magnification.
(B) Gentamicin+SrHNTs+BMP-2 COMA gel-coated PCL sample at 1000×
magnifications. (C) Minocycline+SrHNTs+BMP-2 COMA gel coated PCL sample at
25 × magnifications. (D) Minocycline+SrHNTs+BMP-2 COMA gel coated PCL
sample at 1000 × magnifications. (E) SrHNTs+BMP-2 COMA gel-coated PCL
sample at 25× magnifications. (F) SrHNTs+BMP-2 COMA gel coated PCL sample at
1000× magnifications. (G) COMA gel coated PCL sample at 25× magnifications. (H)
COMA gel coated PCL sample at 1000 × magnifications. (I) PCL sample at 25 ×
magnifications. (J) PCL sample at 1000 × magnifications.
All the filaments were printed into pre-designed structures with a pore size of
1200 m1200 m and a layer height of 400 m. However, the limitations of the 3D
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printer altered the resolution slightly. Therefore, the precise pore size was determined by
a laser confocal microscope (Figure 5-3). Based on the measurement of 16 pores from 1
3D printed scaffold, the average pore size is 1343231 m in vertical distance and
1343231 m in horizontal distance with a porosity of 63.45.7%.

Figure 5-3: (A) Laser confocal image of 3D printed disc. (B) Vertical section of
selected area, the layer thickness was measured (734.57.8 m, n=16). (C) Vertical
section of selected area, the vertical distance of each pore was measured
(1343.25231 m, n=16). (D) Horizontal section of selected area, the horizontal
distance of each pore was measured (1088.5215 m, n=16).
To confirm the existence of SrHNTs and quantify the amount of Sr, energydispersive X-ray spectroscopy (EDS) was used. The EDS results of the
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gentamicin+SrHNTs+BMP-2 COMA gel-coated PCL sample (Figure 5-4) showed
62.47% C, 28.29% O, 4.81% Ca, 3.28% S, 1.14% Au, and no Sr.

Figure 5-4: The EDS graph for each element distribution on a gentamicin+SrHNTs+
BMP-2 COMA gel-coated PCL sample.
The EDS results of minocycline+SrHNTs+BMP-2 COMA gel-coated PCL
sample (Figure 5-5), when compared to gentamicin sample showed that C% increased
from 62.47% to 63.72%, O%, Ca%, S%, and Au% all decreased from 28.29% to 27.5%,
4.81% to 4.55%, 3.28% to 3.23%, and 1.14% to 0.95%, respectively. This change may
reflect the difference between gentamicin sulfate and minocycline. Only 0.02% Sr was
detected.
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Figure 5-5: The EDS graph for each element distribution on minocycline+SrHNTs+
BMP-2 COMA gel-coated PCL sample.
The EDS results of SrHNTs+BMP-2 COMA gel coated PCL sample (Figure
5-6), compared to gentamicin sample, showed that C%, and O% increased from 62.47%
to 63.57%, and from +28.29% to 29.38%, respectively. Ca%, S%, and Au% all decreased
from 4.81% to 3.78%, 3.28% to 2.54%, and 1.14% to 0.69%, respectively. Only 0.01%
Sr was detected.
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Figure 5-6: The EDS graph for each element distribution on SrHNTs+BMP-2 COMA
gel-coated PCL sample.
The EDS results of SrHNTs+BMP-2 COMA gel coated PCL sample compared to
minocycline sample showed that O% increased from 27.5% to 29.38%, C%, Ca%, S%,
and Au% all decreased from 63.72% to 63.57%, 4.55% to 3.78%, 3.23% to 2.54%, and
0.95% to 0.69%, respectively. Only 0.02% Sr was detected.
The EDS results of CoMA gel-coated PCL sample (Figure 5-7) compared to
SrHNTs sample showed that Ca%, S%, and Au% increased from 3.78% to 4.45%, 2.54%
to 3.19%, and 0.69% to 0.87%, respectively. C%, and O% all decreased from 63.57% to
62.68%, and 29.38% to 27.97%, respectively. 0.03% Sr was detected even though there
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was no Sr added to the sample. Therefore, the Sr that was detected is an error. The
amount of Sr may be too low for the EDS to detect.

Figure 5-7: The EDS graph for each element distribution on CoMA gel-coated PCL
sample.
The EDS results of PCL sample compared to CoMA sample (Figure 5-8) showed
that C%, and O% increased from 62.68% to 65.48%, and 27.97% to 30.29%,
respectively. Ca%, S%, and Au% all decreased from 4.45% to 2.32%, 3.19% to 1.88%,
0.87% to 0%, respectively. These changes may be caused by the difference between the
CoMA coating and PCL, as well as the lack of a gold coating on the PCL sample. No Sr
was detected.
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Figure 5-8: The EDS graph for each element distribution on the PCL sample.
To further quantify the amount of Sr loaded into and onto the HNTs, EDXRF was
performed. Under no vacuum condition (Figure 5-9), two Sr radiation signals were
detected. These were caused by the Sr electrons transitioning into different energy levels.
However, one of the radiation signals was too weak to be detected, the Sr signal resulted
in two peaks. Si and Al signals were not present because the no vacuum condition caused
these signals to be absorbed by the air.
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Figure 5-9: Energy Dispersive X-ray Fluorescence (EDXRF) graph for SrHNTs (no
vacuum) element distribution.
Under a vacuum condition (Figure 5-10), three strong Sr signals were detected.
However, one of them was in the same position as the Si signal and covered by the Si
signal. Al and Si signals are also shown in the figure.

Figure 5-10: EDXRF graph for the SrHNTs element distribution.
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In Figure 5-11, three of the Sr signals are displayed. Signals from C and O were
not displayed because these elements use a different spectroscopic crystal from Sr.

Figure 5-11: EDXRF graph for SrCO3 element distribution.
The pure HNTs have strong signals for Al and Si, and barely any signal for Sr. SrHNTs
tested without vacuum have two weak signals (Figure 5-12) compared to SrHNTs and
SrCO3. Since the amount of SrHNTs and SrCO3 were the same, the SrHNTs signal
strength is approximately 45%. The amount of Sr loading into or onto HNTs is
approximately 40-45%.
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Figure 5-12: EDXRF graph for each element distribution. The red line represents the
element distribution result for the HNTs sample. The yellow line represents the
element distribution result for Sr-coated HNTs sample that was tested outside a
vacuum. The green line represents the element distribution results for the Sr-coated
HNTs sample that were tested under vacuum. The black line represents the element
distribution result for the SrCO3 sample.
5.3.2

Compressive Strength
To test the mechanical properties of the 3D scaffold, the PCL samples were

compared to PLA (Figure 5-13). The instrument is limited to a maximum force of 200 N
for the failure test, and at that force, none of the scaffolds failed. Since the compressive
strength varies between 100 and 200 MPa for cortical bone and between 2 and 20 MPa
for cancellous bone, our PCL samples demonstrated that they were strong enough to be
used as bone scaffolds. ANOVA analysis showed a significant difference among the four
groups.
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Figure 5-13: Compression modulus of PCL and PLA. Area: side: 48 mm2, Top: 144
mm2. (Error bars are standard deviations, n=4, p<0.05).
5.3.3

Bacteria Inhibition Study
The CoMA gel and SrHNTs+BMP-2 samples did not have any bacteria inhibition

zone (Figure 5-14). The SrHNTs+BMP-2+Gentamicin and SrHNTs+BMP2+Minocycline samples showed similar inhibition zones compared to gentamicin
standard disks. However, the inhibition zone of SrHNTs+BMP-2+Gentamicin and
SrHNTs+BMP-2+Minocycline samples are smaller than minocycline.
The SrHNTs+BMP-2+Gentamicin and SrHNTs+BMP-2+Minocycline samples
have a larger inhibition zone in Staph.a plate than E. coli plates. However, the size
difference of the inhibition zone of SrHNTs+BMP-2+Minocycline in E. coli and Staph.a
plates is smaller than SrHNTs+BMP-2+Gentamicin samples. Compared to gentamicin
disks, the minocycline disks have a larger inhibition zone in E. coli plates than S.au
plates.

Inhibition Zone Diameter (cm)
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Figure 5-14: Top: Measurement of bacteria inhibition zone. Bottom: Bacteria
inhibition zone. (Error bars are standard deviations, n=3, p<0.05).
5.3.4

Mineralization-Alizarin Red Staining
Cell mineralization, collagen synthesis, and protein secretion are three important

indexes for an early stage of bone repair and regeneration. Thus, we studied the
mineralization and collagen synthesis of the 3D printed scaffolds to determine the
optimal design.
Calcium deposition can be identified by Alizarin Red stain. The Alizarin Red
stain calcium complex chelates with calcium and presents red color under a microscope
at a bright field. As shown in Figure 5-15, PCL samples exhibited minimal calcium

CoMA
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deposition, and the samples coated with COMA gel had more calcium deposition.
Calcium deposition increased with incubation time. The gentamicin +SrHNTs+BMP-2
COMA gel-coated group, SrHNTs+BMP-2 COMA gel-coated group, and COMA gelcoated group had approximately the same amount of calcium deposition. To further
confirm the amount of calcium deposition, the UV absorbance was measured.

Figure 5-15: Alizarin Red Staining of cells after 7-, 14-, and 21-days incubation.
Dark red represented calcium deposition.
The UV absorbance results (Figure 5-16) showed that the amount of calcium
deposition in the scaffolds coated with COMA gel was significantly higher than in the
PCL scaffolds. On day 21, the gentamicin+SrHNTs+BMP-2 (G+SrB) group had the
highest amount of calcium deposition in the COMA gel-coated groups. The
SrHNTs+BMP-2 (SrB) group had the second-highest amount of calcium deposition in the
COMA gel-coated groups. Minocycline+ SrHNTs+BMP-2 (M+SrB) group had the
lowest amount of calcium deposition in the COMA gel-coated groups.
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Figure 5-16: UV absorbance for Alizarin Red Staining of cells after 7-, 14-, and 21days incubation. (Error bars are standard deviations, n=3, p<0.05).
5.3.5

Picrosirius Red Staining
Sirius Red dye is strongly acidic, and it easily binds to basic groups in collagen

molecules. Under an ordinary optical microscope, collagen is dyed red, and muscle fibers
and cytoplasm are dyed yellow. Figure 5-17 shows images from the bottom layer of the
3D scaffolds, and Figure 5-18 shows images from the top layer. Cells attached and grew
on the gentamicin+SrHNTs+BMP-2 and Minocycline+ SrHNTs+BMP-2 scaffolds on
day 7. Some collagen fibers were synthesized in between cells on the
gentamicin+SrHNTs+BMP-2 and Minocycline+ SrHNTs+BMP-2 scaffolds on day 7. On
day 7, SrHNTs+BMP-2 and COMA gel groups also had some cells grow, but not as clear
as the gentamicin+SrHNTs+BMP-2 and Minocycline+ SrHNTs+BMP-2 groups.
SrHNTs+BMP-2 scaffolds had more collagen fibers synthesized than COMA scaffolds.
Few cells grew on the PCL scaffolds, and no obvious collagen fibers were synthesized.
Cell proliferation and collagen fibers increased with incubation time. On day 21, all gel-
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coated scaffolds had high cell density on the surface. Most collagen fibers were formed
under the cells. However, PCL scaffolds still had minimal cell attachment and growth,
with minimal collagen fiber formation on the surface. Minocycline+SrHNTs+BMP-2
groups had the lowest number of cells and collagen fibers.

Figure 5-17: Picrosirius Red Stain for the bottom layer of 3D scaffolds.

Figure 5-18: Picrosirius Red Stain for the top layer of 3D scaffolds.
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5.4

Conclusions

The CoMA gel and SrHNTs+BMP-2 samples had no bacteria inhibition zone.
The SrHNTs+BMP-2+Gentamicin and SrHNTs+BMP-2+Minocycline samples showed
similar inhibition zones compared to gentamicin standard disks (10 µg). However, the
inhibition zone of SrHNTs+BMP-2+Gentamicin and SrHNTs+BMP-2+Minocycline
samples are smaller than minocycline standard disks (30 µg). The mineralization results
showed that the amount of calcium deposition in the scaffolds coated with COMA gel is
significantly higher than the PCL scaffolds. On day 21, the gentamicin+SrHNTs+BMP-2
(G+SrB) group had the highest amount of calcium deposition in the COMA gel-coated
groups. The collagen synthesis study showed that all gel-coated scaffolds had substantial
cell growth on the surface. Most collagen fibers were formed under the cells. However,
PCL scaffolds still had few cells attached or growing on the surface. However,
Minocycline+ SrHNTs+BMP-2 groups had the lowest number of cells and collagen
fibers in COMA gel-coated groups. Few collagen fibers formed on the PCL scaffolds
after 21 days of incubation.
5.5

Discussion

We designed large pores for our scaffolds so that the COMA gel can enter the
scaffolds and cover their insides. The confocal image showed that there is a difference
between the 3D printed bracket and our design, which is caused by a lack of precision in
the 3D printer. At the same time, PCL does not tolerate high temperatures, and it will
deform to a certain extent after cooling, which also affects the final printing result.
Base on the bacteria inhibition study, we found gentamicin and minocycline had a
similar inhibition zone. This indicated two antibiotics have no significant difference in
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antibacterial effects. However, the gentamicin sample showed superiority over the
minocycline sample in terms of calcium deposition, cell growth, and collagen fiber
synthesis.

CHAPTER 6
DISCUSSION
These three projects were undertaken to explore the potential application of
halloysite nanotubes and BMP-2 in bone disease repair and bone regeneration medical
devices. Critical in our design was to determine the osteoblast's migration rate in
response to different concentrations of HNTs, BMP-2, and HNTs combine with BMP-2.
Previous research has already demonstrated that the incorporation of HNTs can enhance
bone regeneration [258-260]. In addition, BMP-2 is another agent that strongly promotes
bone formation in vitro and in vivo [261,262]. A recent study by Huang et al. (2019) has
provided support for this observation [263].
Several previous studies have used exogenous growth factors to recruit
osteoblasts to the damaged site for a better therapeutic outcome [7,8,264]. As a result, the
delivery of growth factors to the damaged site has become a widely used methodology
that facilitates tissue repair by enhancing host cell recruitment, proliferation, and
activation [265,266]. This approach has shown that faster recruitment of repair cells to
the defect site can significantly reduce the time required for bone tissue repair and
remodeling and can thus enhance bone reconstruction. However, clinicians currently use
large amounts of BMP-2 (up to 40 mg) for bone repair [7,8,265]. From the amount of
BMP-2 used, only 75 µg binds to 1 g of collagen [266]. Mature recombinant BMP is not
soluble at neutral pH and thus the leftover BMP-2 tends to form large molecular weight
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(MW) agglomerates, which in combination with bovine collagen can induce significant
inflammation, swelling, and heterotopic ossification in other areas [266]. Therefore, this
research is important because it provides a possible approach for designing a safe and
cost-effective in situ method of bone repair. In this study, BMP-2 and HNTs showed a
mutual promotion in the recruitment of osteoblasts. The additive of Sr especially
significantly increased pre-osteoblasts differentiation and osteogenesis in vitro. As
discussed in Chapter 5, SrHNTs+BMP-2 COMA nanocomposites PCL scaffolds showed
not only superior mechanical properties but also a huge osteogenesis potential. In the
presence of all groups of COMA nanocomposites, pre-osteoblasts synthesize the collagen
fibers leading to the early formation of the collagen matrix and calcium deposition. On
the one hand, the gentamicin coating did not significantly inhibit cell growth. On the
other hand, minocycline coating showed a low-level inhibitory effect on the growth of
pre-osteoblasts. By day 21, the gentamicin+SrHNTs+BMP-2 COMA-coated scaffolds
showed significantly increased and incomparable cell proliferation capacity compared to
the PCL group. Therefore, gentamicin+SrHNTs+BMP-2 COMA-coated scaffolds can not
only prevent bacterial contamination but also promote bone regeneration at the same
time.
Some research shows that a COMA-composed nanoparticles system improved not
only its hydrogel’s mechanical properties but also its bioactivity. Kajave et al. [267]
created a bioactive ink composed of Bioglass 45S5 (BG) and methacrylated collagen
(CMA) for 3D printed bone tissue. They showed a similar result to our study, BG
incorporated CMA (BG-CMA) constructs maintained high cell viability of human
mesenchymal stem cells. BG-CMA constructs showed a higher cell-mediated calcium
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deposition compared to CMA alone. In addition, BG particles within the collagen
network improved stability and reduced the swelling of collagen hydrogels. Similarly,
Kim et al. [268] introduced a bioceramic-based cell-printing technique and a cell
(MC3T3)-laden ceramic (α-tricalcium phosphate (α-TCP) type I collagen) structure.
Their results showed that the scaffold had good cellular activities, including metabolic
activity and mineralization. In another research, Kajave et al. [269] provided a viable
strategy to yield mechanically superior, cell compatible, and printable CMA hydrogels
that used a dual crosslinking mechanism. Dual crosslinking was performed by first
photochemical crosslinking of CMA hydrogels, followed by chemical crosslinking with
two different concentrations of genipin (i.e., 0.5 mM (low dual) or 1 mM (high dual)). In
this way, they improved the photochemical crosslinking of CMA hydrogels’ mechanical
weakness, increased degradation time in vivo, and kept its high cell viability.
Similar systems such as gelatin methacrylate (GelMA) composed nanotube
system also showed results like ours. Shin et al. added carbon nanotubes (CNTs) into
GelMA hydrogels to enhance their stiffness without inhibiting 3D cellular growth [270].
Huang et al. [271] proposed a biomimetic GelMA/nano fish bone hybrid hydrogel to
systematically investigate its potential for bone regeneration. The results showed that
nano fish bone incorporation enhanced the mechanical performance of the hybrid
hydrogel and improved bone regeneration. Ou et al. [272] fabricated a
nanosilver/halloysite nanotubes/gelatin methacrylate (nAg/HNTs/GelMA) hybrid
hydrogel and evaluated its osteoimmunomodulatory and antibacterial properties in vitro
and in vivo. The results showed that nAg/HNTs/GelMA hydrogel not only had good
biocompatibility with human periodontal ligament stem cells (hPDLSCs) and
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macrophages but also enhanced the osteogenic differentiation. Moreover, compared with
HNTs/GelMA hydrogel, the nAg/HNTs/GelMA hydrogel significantly showed a stronger
antiinfection ability of Gram-positive and Gram-negative bacteria in vitro and in vivo.
Above all, all these results support what our research found. Our result showed a
significantly higher osteocalcin concentration level and more calcium deposition
compared to the research mentioned above. Secondly, we added an antimicrobial effect
against Gram-positive and Gram-negative bacteria to our scaffolds. Thirdly, we reduced
the BMP-2 concentration level from mg/ml to ng/ml, a significant breakthrough.
Meanwhile, our research has provided many discoveries and new choices in BTE
materials. An example of this is the information we provided on the early formation of
collagen matrix on a COMA nanocomposite scaffold.
Currently, a limitation for repairing large bone defects is the formation of blood
vessels. If the 3D printed scaffold is too big, it could affect blood vessel formation.
Recent research showed some large bone defect models of rabbits’ mandibles (26 × 5 × 3
mm) exceeded the critical size which is reported as a basic length of about 15 mm
[273,274] to achieve regeneration [275]. They designed a dual delivery of BMP-2 and
basic fibroblast growth factor (bFGF) from a new nano-composite scaffold loaded with
vascular stents [275]. This provides us with a new method to repair and regenerated large
bone defects.

CHAPTER 7
CONCLUSIONS AND FUTURE WORK

7.1

Conclusions

In Project #1, we found that HNT groups have the highest migration rate when
they have 250 μg/ml concentration. Of the BMP-2 groups, 5 ng/ml BMP-2 showed the
most migrated cells. When HNTs are present in the medium, 5 ng/ml BMP-2 had the
highest migration rate. Especially the group which has 5 ng/ml BMP-2 and 50 μg/ml
HNTs. All these results indicate that the HNTs and HNTs doped with BMP-2 can
become a new agent for use in bone regeneration.
In Project #2, In the degradation study, the 4% CoMA group degraded faster than
the 8% group. In the 4% CoMA group, samples crosslinked for 14 min degraded faster
than samples crosslinked for 18 min. The contact angel results show that SrHNTs 4% 14
min CoMA hydrogel had the smallest contact angel at 80 seconds. SrHNTs and BMP-2
4% 14 min CoMA hydrogel had the second smallest contact angle at 80 seconds. All
samples showed a similar proliferation rate. The differentiation results demonstrated that
SrHNTs and BMP-2 CoMA 4% 18 min-crosslinked hydrogels enhanced preosteoblasts
differentiation and osteogenesis in vitro.
In Project #3, The CoMA gel and SrHNTs+BMP-2 samples had no bacteria
inhibition zone. The SrHNTs+BMP-2+Gentamicin and SrHNTs+BMP-2+Minocycline
samples showed similar inhibition zones compared to gentamicin standard disks (10 µg).
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However, the inhibition zone of SrHNTs+BMP-2+Gentamicin and SrHNTs+BMP2+Minocycline samples are smaller than minocycline standard disks (30 µg). The
mineralization results showed that the amount of calcium deposition in the scaffolds
coated with COMA gel is significantly higher than the PCL scaffolds. On day 21,
gentamicin+SrHNTs+BMP-2 (G+SrB) group had the highest amount of calcium
deposition in the COMA gel-coated groups. The collagen synthesis study showed that all
gel-coated scaffolds had substantial cell growth on the surface. Most collagen fibers were
formed under the cells. However, PCL scaffolds still had few cells attached or growing
on the surface. However, Minocycline+ SrHNTs+BMP-2 groups had the lowest number
of cells and collagen fibers in COMA gel-coated groups. Few collagen fibers formed on
the PCL scaffolds after 21 days of incubation.
7.2

Future Work

Since we have confirmed the optimal combination of the COMA-coated scaffold,
the next stage is to explore its application in biomedical engineering through animal
testing. Animal testing will provide us with more information on how the scaffold works
in vivo. If the scaffold works ideally, it will provide a meaningful treatment plan for bone
tissue repair and regeneration. Meanwhile, this technology can be used not only for bone
repair and regeneration but also for the repair and regeneration of other tissues. In
addition, COMA hydrogel can also be combined with other materials, such as
Polyurethane (PU), Polylactic (PLA), and silk protein, other structures, such as
microspheres and films, and other biological factors, such as vascular endothelial growth
factor (VEGF), hepatocyte growth factor (HGF), activin-A, epidermal growth factor

94
(EGF), and transforming growth factor β (TGF-β), to develop more personalized designs.
This technology opens multiple directions for further exploration.
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